Proxy Statement (Form DEF 14A)
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒
|
Definitive Proxy Statement
|
☐
|
Definitive Additional Materials
|
☐
|
Soliciting Material under § 240.14a-12
|
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒
|
No fee required
|
☐
|
Fee paid previously with preliminary materials.
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
(646) 443-8550
Dear Shareholder:
You are cordially invited to attend the 2025 Annual Meeting of Shareholders, which will be held at the offices of Kramer Levin Naftalis & Frankel LLP , 1177 Avenue of the Americas , New York, NY 10036 at 10:00 a.m. on Tuesday, May 20, 2025 . Your Board of Directors looks forward to greeting those shareholders that are able to attend. On the following pages you will find the formal Notice of Annual Meeting and Proxy Statement.
For the Annual Meeting, we are pleased to take advantage of the "Notice and Access" rule adopted by the Securities and Exchange Commission to furnish proxy materials to shareholders over the internet. We believe this process will provide you with an efficient and quick way to access your proxy materials and vote your shares, while allowing us to reduce the environmental impact of our Annual Meeting and the costs of printing and distributing the proxy materials. On or about April 9, 2025 , we intend to mail to most shareholders only a Notice of Internet Availability of Proxy Materials that tells them how to access and review information contained in the proxy materials and vote electronically over the internet. If you received only the Notice in the mail, you will not receive a printed copy of the proxy materials in the mail unless you request the materials by following the instructions included in the Notice.
At the Annual Meeting, you will be asked to (i) elect seven Directors, (ii) approve a non-binding, advisory resolution regarding the compensation of our named executive officers; and (iii) ratify the appointment of Deloitte & Touche LLP as the company's auditors for the fiscal year ending December 31, 2025 . Your Board of Directors recommends that you vote your shares "FOR" proposals (i), (ii), and (iii). These proposals are more fully described in the accompanying proxy statement.
All individuals attending the meeting must comply with then-applicable health and safety orders or guidelines and comply with any additional rules and regulations that Company personnel or the manager of the venue determines are necessary or desirable to protect the health and safety of attendees. In addition, to attend the meeting, you must provide proof of ownership of our stock as provided below under "Proof of Ownership Required for Attending Meeting in Person."
Whether or not you expect to attend the Annual Meeting, it is important that your shares be represented. Please vote your shares using the internet or a toll-free telephone number, or by requesting a printed copy of the proxy materials and completing and returning by mail the proxy card and you will receive in response to your request. Instructions on using each of these voting methods are outlined in the proxy statement. Your cooperation will ensure that your shares are voted.
Thank you for your continued support.
|
|
|
|
|
|
Sincerely,
|
|
|
|
|
|
|
|
Chairman of the Board
|
|
|
|
|
|
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD ON MAY 20, 2025
NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders (the "Annual Meeting") of Genco Shipping & Trading Limited , a Marshall Islands corporation ("Genco"), will be held on May 20, 2025 at 10:00 a.m. (local time), at the offices of Kramer Levin Naftalis & Frankel LLP , 1177 Avenue of the Americas , New York, NY 10036 for the following purposes:
1.
|
To elect the seven directors named in the proxy statement to the Board of Directors of Genco;
|
2.
|
To approve a non-binding, advisory resolution regarding the compensation of Genco's named executive officers;
|
3.
|
To ratify the appointment of
|
4.
|
To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
Shareholders of record at the close of business on March 28, 2025 are entitled to notice of, and to vote at, the Annual Meeting or any adjournment or postponement thereof. A list of such shareholders will be available at the Annual Meeting.
All shareholders are cordially invited to attend the Annual Meeting. If you do not expect to be present at the Annual Meeting, you are requested to fill in, date and sign the enclosed proxy and mail it promptly in the enclosed envelope to make sure that your shares are represented at the Annual Meeting. Shareholders of record also have the option of voting by using a toll-free telephone number or via the Internet. Instructions for using these services are included on the proxy card. In the event you decide to attend the Annual Meeting in person, you may, if you desire, revoke your proxy and vote your shares in person in accordance with the procedures described in the accompanying proxy statement.
YOUR VOTE IS IMPORTANT
IF YOU ARE UNABLE TO BE PRESENT PERSONALLY, PLEASE VOTE BY TELEPHONE, INTERNET, OR BY MAIL. PLEASE REFER TO THE ENCLOSED PROXY FOR INFORMATION ON HOW TO VOTE BY TELEPHONE OR INTERNET. IF YOU CHOOSE TO VOTE BY MAIL, PLEASE MARK, SIGN AND DATE THE ENCLOSED PROXY, WHICH IS BEING SOLICITED BY THE BOARD OF DIRECTORS, AND RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE.
|
|
|
|
|
|
By Order of the Board of Directors,
|
|
|
|
|
|
|
|
Chief Executive Officer and President
|
|
|
|
|
|
(646) 443-8550
PROXY STATEMENT
ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD MAY 20, 2025
This proxy statement is furnished to shareholders of Genco Shipping & Trading Limited ("Genco" or the "Company") in connection with the solicitation of proxies, in the accompanying form, by the Board of Directors of Genco (the "Board") for use in voting at the Annual Meeting of Shareholders (the "Annual Meeting") to be held at Kramer Levin Naftalis & Frankel LLP , 1177 Avenue of the Americas , New York, NY 10036 on May 20, 2025 at 10:00 a.m. , and at any adjournment or postponement thereof.
This proxy statement and the accompanying form of proxy or the Notice of Internet Availability are first being mailed to shareholders on or about April 9, 2025 .
VOTING RIGHTS AND SOLICITATION OF PROXIES
Purpose of the Annual Meeting
The specific proposals to be considered and acted upon at the Annual Meeting are summarized in the accompanying Notice of Annual Meeting of Shareholders. Each proposal is described in more detail in this proxy statement.
Record Date and Outstanding Shares
The Board has fixed the close of business on March 28, 2025 as the record date (the "Record Date") for the determination of shareholders entitled to notice of, and to vote at, the Annual Meeting. Only shareholders of record at the close of business on that date will be entitled to vote at the Annual Meeting or any and all adjournments or postponements thereof. As of March 28, 2025 , Genco had issued and outstanding 42,959,464 shares of common stock. The common stock comprises all of Genco's issued and outstanding voting stock.
Revocability and Voting of Proxies
Any person signing a proxy in the form accompanying this proxy statement has the power to revoke it prior to the Annual Meeting or at the Annual Meeting prior to the vote pursuant to the proxy. A proxy may be revoked by any of the following methods:
•
|
by writing a letter delivered to
|
•
|
by submitting another proxy with a later date; or
|
•
|
by attending the Annual Meeting and voting in person.
|
Please note, however, that if you are a shareholder who beneficially owns shares that are held of record by your broker, bank or other nominee and you wish to vote at the Annual Meeting, you must first request and bring to the meeting a "legal proxy" from your broker, bank or other nominee.
All shares represented by valid proxies received and not revoked before they are exercised will be voted in the manner specified in the proxy.
If you are a shareholder of record and you properly sign, date and retua proxy card, but do not indicate how you wish to vote with respect to a particular nominee or proposal, then your shares will be voted "FOR" the election of such nominee and "FOR" the approval of each proposal. If you indicate a choice with respect to any matter to be acted upon when voting via the Internet (or by telephone or on your returned proxy
1
card) and you do not validly revoke it, your shares will be voted in accordance with your instructions. If you do not vote via the Internet or by telephone or sign, date and retua proxy card, you must attend the annual meeting in person in order to vote. If the shares you own are held in your bank or brokerage firm account in a fiduciary capacity (typically referred to as being held in "street name"), you can vote by following the directions provided to you by your bank or brokerage firm. If the shares you own are held in street name and you wish to vote in person at the annual meeting, you must obtain a "legal proxy" from the organization that holds your shares. A legal proxy is a written document that will authorize you to vote your shares held in street name at the annual meeting. Please contact the organization that holds your shares for instructions on how to obtain a legal proxy. You must bring a copy of the legal proxy to the annual meeting and present it with your ballot in order for your vote to be counted.
If you hold your shares through an account with a bank or broker, your shares may be voted by the bank or broker if you do not provide specific voting instructions. Banks and brokers have the authority under New York Stock Exchange ("NYSE") rules to vote shares for which their customers do not provide voting instructions on routine matters. The proposal to ratify the appointment of our independent auditors is a routine matter that is considered a "discretionary" item under NYSE rules. This means that banks and brokers may vote in their discretion on this matter on behalf of clients who have not furnished voting instructions at least ten days before the date of the annual meeting.
The proposals to elect directors and to approve a non-binding, advisory resolution regarding the compensation of Genco's named executive officers are non-routine matters for which brokers do not have discretionary voting power and for which specific instructions from beneficial owners are required. As a result, brokers are not allowed to vote on this proposal on behalf of beneficial owners if such owners do not retuspecific voting instructions.
Voting at the Annual Meeting
Each share of common stock outstanding on the Record Date will be entitled to one vote on each matter submitted to a vote of the shareholders, including the election of directors. Cumulative voting by shareholders is not permitted.
The presence, in person or by proxy, of the holders of a majority of the votes entitled to be cast by the shareholders entitled to vote at the Annual Meeting is necessary to constitute a quorum. Abstentions and broker "non-votes" are counted as present and entitled to vote for purposes of determining a quorum. A broker "non-vote" occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power for that particular item and has not received instructions from the beneficial owner.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal
|
|
|
Vote Required
|
|
|
Effect of
Abstentions
|
|
|
Effect of
Broker "Non-Votes"
|
|
1.
|
|
|
Election of Directors
|
|
|
Plurality of votes cast
|
|
|
No effect
|
|
|
No effect
|
|
|
|
|
|
|
|
|
|||||
2.
|
|
|
Advisory Vote on Executive Compensation
|
|
|
Affirmative vote of a majority of the common shares represented and entitled to vote
|
|
|
Same effect as a vote "against"
|
|
|
No effect
|
|
|
|
|
|
|
|
|
|||||
3.
|
|
|
Ratification of Appointment of Independent Auditors
|
|
|
Affirmative vote of a majority of the common shares represented and entitled to vote
|
|
|
Same effect as a vote "against"
|
|
|
No effect
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For directions to be able to attend the meeting and vote in person, please contact us by sending an e-mail to finance@gencoshipping.com.
2
Proof of Ownership Required for Attending Meeting in Person
You are entitled to attend the Annual Meeting only if you are a stockholder as of the close of business on March 28, 2025 , the record date, or hold a valid proxy for the meeting. In order to be admitted to the 2025 Annual Meeting, you must present proof of ownership of company stock on the record date. This can be:
•
|
a brokerage statement or letter from a bank or broker indicating ownership on
|
•
|
a proxy card,
|
•
|
a voting instruction form, or
|
•
|
a legal proxy provided by your broker, bank or other nominee.
|
Any holder of a proxy from a stockholder must present the proxy card, properly executed, and a copy of the proof of ownership. Stockholders and proxy holders must also present a form of photo identification such as a driver's license. We will be unable to admit anyone who does not present identification or refuses to comply with our security procedures.
Solicitation
We will pay the costs relating to this proxy statement, the proxy and the Annual Meeting. We may reimburse brokerage firms and other persons representing beneficial owners of shares for their expenses in forwarding solicitation material to beneficial owners. Directors, officers and regular employees may also solicit proxies. They will not receive any additional pay for the solicitation.
Important Notice Regarding the Availability of Proxy Materials for the
Annual Meeting of Shareholders to Be Held May 20, 2025 .
Our Proxy Statement and Annual Report to Shareholders are
available at www.proxyvote.com.
Your vote is important. Thank you for voting.
3
PROPOSAL NO. 1
ELECTION OF DIRECTORS
Under Genco's Certificate of Incorporation, as amended, all members of the Board of Directors currently have terms expiring at the 2025 Annual Meeting. The Board of Directors has nominated the directors currently serving on the Board of Directors for election or re-election to serve as directors of the Company for a one-year term until the 2026 Annual Meeting of Shareholders of the Company and until their successors are elected and qualified or until their earlier resignation or removal. Although management has no reason to believe that the nominees will not be available as candidates, should such a situation arise, proxies may be voted for the election of such other persons as the holders of the proxies may, in their discretion, determine.
Directors are elected by a plurality of the votes cast at the Annual Meeting, either in person or by proxy. Votes that are withheld will be excluded entirely from the vote and will have no effect. However, any director who receives a greater number of votes "withheld" than votes "for" his or her election in an uncontested election must promptly tender his or her resignation in writing to the Nominating and Corporate Governance Committee of the Board for consideration and recommendation to the Board for action. See "Director Resignation Policy" on p. 8 for further information.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE "FOR" THE ELECTION (ITEM 1 ON THE ENCLOSED PROXY CARD) OF THE NOMINEES AS DIRECTORS.
Nominee Information
The following table sets forth information regarding the nominees for re-election as directors:
|
|
|
|
|
|
|
|
|
|
Age
|
|
|
Position
|
|
|
|
57
|
|
|
Chairman of the Board and Director
|
|
|
|
48
|
|
|
Director
|
|
|
|
70
|
|
|
Director
|
|
|
|
77
|
|
|
Director
|
|
|
|
55
|
|
|
Director
|
|
|
|
62
|
|
|
Director
|
|
|
|
54
|
|
|
Chief Executive Officer, President, Secretary, and Director
|
|
|
|
|
|
|
|
4
LLC and a member of the Board of Directors of Rio Tinto Services Inc. since 2019; General Manager, Marketing and Development, Metals, and Head of the Chicago Commercial Office from 2018 to 2022, and Chief of Staff/Group Business Executive to the Rio Tinto Group CEO from 2016 to 2017. Prior to her tenure at Rio Tinto , Ms. Das served as Chief Strategy Officer for Consortium at Sumitomo Corporation , Itochu Corporation , UACJ Consortium and Head of Strategic Planning & Performance at BP. Ms. Das has served on the Board of Coeur Mining, Inc. since May 2023 , the Board of Toromont Industries since November 2024 , and the Advisory Board of Durendal Resources , a company in the business of AI-backed, geoscience-based metals exploration since March 2024 . She earned a Master of Business Administration from the University of Louisville , Executive Education from University of Chicago and a Bachelors' Degree from Guru Govind Singh Indraprastha University . As a result of these and other professional experiences, Genco believes Ms. Das possesses knowledge and experience regarding commodities markets, ESG matters, and general business matters that strengthen the Board's collective qualifications, skills and experience.
5
6
mergers and acquisitions, equity fund management, debt placement and equity placement in the shipping industry. From 1993 through 2000, he worked in the international maritime lending group of The First National Bank of Maryland , serving as a Vice President from 1998. Mr. Wobensmith has a Bachelor's Degree in economics from St. Mary's College of Maryland . He also was appointed by the Governor of Maryland and currently serves on the Board of Trustees and as Treasurer of the Board at St. Mary's College of Maryland . Mr. Wobensmith holds the Chartered Financial Analyst designation.
Corporate Governance
Governance Materials- All of the Company's corporate governance materials, including the committee charters of the Board and the Company's Corporate Governance Guidelines, are published in the Governance Documents page of the Governance section of the Company's website under "Investors" at www.gencoshipping.com. These materials are also available in print to any shareholder upon request. The Board regularly reviews corporate governance developments and modifies its committee charters as warranted. Any modifications are reflected on the Company's website.
Director Independence- It is the Genco Board's objective that a majority of the Genco Board consist of independent directors. For a director to be considered independent, the Genco Board must determine that the director does not have any material relationship with Genco. The Genco Board follows the criteria set forth in applicable NYSE listing standards to determine director independence. The Genco Board will consider all relevant facts and circumstances in making an independence determination.
All members of the Genco Audit, Compensation, and Nominating and Corporate Governance Committees must be independent directors as defined by applicable NYSE listing standards. Members of the Genco Audit Committee must also satisfy a separate SEC independence requirement, which provides that they may not accept directly or indirectly any consulting, advisory or other compensatory fee from Genco or any of its subsidiaries other than their director compensation.
The independent directors of Genco are James G. Dolphin , Paramita Das , Kathleen C. Haines , Basil G. Mavroleon , Karin Y. Orsel and Arthur L. Regan . In determining that Mr. Mavroleon is independent, the Board considered that Mr. Mavroleon is an independent contractor of WeberSeas (Hellas) S.A. ("WeberSeas"), which has acted as a broker introducing potential buyers to Genco in connection with sales of certain of Genco's vessels. The Board deemed Mr. Mavroleon's relationship with WeberSeas not to be material, as Mr. Mavroleon has not received any payment or other economic benefit from any Genco vessel sales and has recused himself from participating in such Genco vessel sales. Genco has not engaged WeberSeas as broker for vessel sales since 2021.
Board Diversity- Our Nominating and Corporate Governance Committee considers many factors when determining the eligibility of candidates for nomination to the Board. In the event of a vacancy, the Committee's goal is to nominate candidates from a broad range of experiences and backgrounds who can be additive to the skill set of the existing board and who can contribute to the Board's overall effectiveness in meeting its mission. In considering candidates, the Board seeks talents, skills, diversity, and expertise to serve the long-term interests of the Company and our stockholders. Three of the seven members of Genco's Board are women, one of whom is of Asian ethnicity.
Board Performance- In accordance with NYSE rules, our Board and its four standing committees assess their performance annually. In addition, in 2024, the Board established an annual process for our directors to conduct individual self-assessments.
Code of Ethics- All directors, officers, employees and agents of Genco must act ethically at all times and in accordance with the policies comprising Genco's Code of Ethics. Under Genco's Code of Ethics, the Genco Board will only grant waivers for a director or an executive officer in limited circumstances and where circumstances would support a waiver. Such waivers may only be made by the Audit Committee.
Genco's Code of Ethics is available in the Governance Documents page of the Governance section of the Company's website under "Investors" at www.gencoshipping.com and is available in print to any shareholder upon request. Genco intends to provide any disclosures regarding the amendment or waiver of its Code of Ethics on its website.
Insider Trading Policies and Procedures- Genco has adopted an Inside Information, Market Communications and Securities Trading Policy and Procedures governing the purchase, sale, and/or other
7
dispositions of its securities by directors, officers and, employees that are reasonably designed to promote compliance with insider trading laws, rules and regulations, and any NYSE listing standards applicable to Genco. A copy of this policy is available as Exhibit 19.1 to our Annual Report on Form 10-K filed with the SEC on February 21, 2025 .
Director Resignation Policy- Under our Corporate Governance Guidelines, at any shareholder meeting at which directors are subject to an uncontested election, any director who receives a greater number of votes "withheld" than votes "for" his or her election, must promptly (and in no event later than ten days) after the certification of the shareholder vote, tender his or her resignation in writing to the Nominating and Corporate Governance Committee of the Board for consideration. The Nominating and Corporate Governance Committee will then assess the appropriateness of such individual continuing to serve as a director and recommend to the Board the action to be taken with respect to such tendered resignation.
Other Directorships and Business Activities- Our Corporate Governance Guidelines prohibit directors from serving on more than four other public company boards. In addition, members of the Audit Committee may not serve simultaneously on the audit committees of more than two other public company boards, unless the Board determines that such simultaneous service would not impair such director's ability to serve effectively on the Audit Committee. Every director must promptly advise and consult with the Chair of the Nominating and Corporate Governance Committee before accepting nomination for or membership on another public company board, if the director changes or retires from the business position he or she previously held; or if the company with which he or she is affiliated undertakes business activities different from those previously pursued. In such a case, the Chair may consult with the Nominating and Governance Committee , other directors, management, or the full Board, and the director may also consult with such Committee or the full Board.
Communicating Concerns to Directors- Shareholders or other interested parties may communicate directly with any individual director, with the Genco Board as a group, with the Chairman or other presiding director pursuant to Section 303A.03 of the NYSE's Listed Company Manual. All of Genco's directors other than Mr. Wobensmith are currently independent and non-management directors. All communications should be in writing and should be addressed to the intended recipient(s), c/o John C. Wobensmith , Secretary, 299 Park Avenue , 12th Floor, New York, New York 10171. Once the communication is received by the Secretary, the Secretary reviews the communication. Communications that comprise advertisements, solicitations for business, requests for employment, requests for contributions or other inappropriate material will not be forwarded to Genco's directors. Other communications are promptly forwarded to the addressee.
Board Meetings and Committees
During fiscal year 2024, there were 12 meetings of the Genco Board of Directors. Genco's Board of Directors in 2024 was comprised of James G. Dolphin , Paramita Das (appointed March 4, 2024 ), Kathleen C. Haines , Basil G. Mavroleon , Karin Y. Orsel , Arthur L. Regan , and John C. Wobensmith . A quorum of directors was present, either in person or telephonically, for all of its meetings in 2024. Actions were also taken during the year by unanimous written consent of Genco's directors. All directors attended at least 75% of the aggregate of the total number of meetings of the Genco Board of Directors and the total number of meetings of all Committees of the Genco Board of Directors on which they served. Genco encourages all directors to attend each annual meeting of shareholders. Seven directors attended the 2024 Annual Meeting of Shareholders.
Genco's Audit Committee was comprised of Kathleen C. Haines (Chair), James G. Dolphin , and Basil G. Mavroleon until July 1, 2024 . Effective July 1, 2024 , the Audit Committee was comprised of Kathleen C. Haines (Chair), James G. Dolphin , and Arthur L. Regan . Ms. Haines is a financial expert as defined under Item 401(h)(2) of Regulation S-K. All of these individuals qualify (or qualified) as independent directors under the listing requirements of the NYSE and are financially literate. Through its written charter, Genco's Audit Committee has been delegated the responsibility of reviewing with the independent auditors the plans and results of the audit engagement, reviewing the adequacy, scope and results of the internal accounting controls and procedures, reviewing the degree of independence of the auditors, reviewing the auditor's fees and recommending the engagement of the auditors to the full Board. During fiscal year 2024, Genco's Audit Committee held four meetings.
Genco's Compensation Committee was comprised of Basil G. Mavroleon (Chair), James G. Dolphin , and Kathleen C. Haines until July 1, 2024 . Effective July 1, 2024 , the Compensation Committee was comprised of Basil G. Mavroleon (Chair), Paramita Das , and Kathleen C. Haines . All of these individuals qualify (or qualified)
8
as independent directors under the listing requirements of the NYSE, and none of them is (or was) an employee of Genco. Through its written charter, Genco's Compensation Committee administers Genco's cash bonus and equity incentive plans and other corporate benefits programs. Genco's Compensation Committee also considers from time to time matters of compensation philosophy and competitive status, and also reviews, approves, or recommends salaries, cash bonuses, equity grants and other compensation in accordance with the terms of Genco's 2015 Equity Incentive Plan and its Annual Incentive Plan. Genco's Compensation Committee generally does not delegate its authority, although Genco's officers are responsible for the day-to-day administration of the 2015 Equity Incentive Plan and the Annual Incentive Plan. Directors' compensation is established by the Genco Board of Directors upon the recommendation of Genco's Compensation Committee. During fiscal year 2024, Genco's Compensation Committee held six meetings.
Genco's Nominating and Corporate Governance Committee was comprised of James G. Dolphin , Basil G. Mavroleon , and Karin Y. Orsel during fiscal year 2024. All of these individuals qualify (or qualified) as independent directors under the listing requirements of the NYSE, and none of them is (or was) an employee of Genco. Through its written charter, the Nominating and Corporate Governance Committee assists the Board in identifying qualified individuals to become Board members, in determining the composition of the Board and its committees, in monitoring a process to assess Board effectiveness and in developing and implementing Genco's corporate governance guidelines. When a vacancy exists on the Board, or when the Board determines to add an additional director, the Nominating and Corporate Governance Committee seeks out appropriate candidates from various sources, which may include directors, officers, employees and others. The Committee may use consultants and search firms who may be paid fees for their assistance in identifying and evaluating candidates. Genco retained KoFerry during 2023 and 2024 for this purpose. The Committee does not have a set of minimum specific qualifications that must be met by a candidate for director and will review the candidate's background, experience and abilities, and the contributions the candidate can be expected to make to the collective functioning of the Board and the needs of the Board at the time. The Committee considers candidates based on materials provided, and will consider whether an interview is appropriate. The Committee will consider shareholder recommendations of director candidates, which should be sent to the attention of the corporate secretary at Genco headquarters, on the same basis. Only persons who are nominated with the procedures set forth in our Amended and Restated By-Laws are eligible for election as directors at our shareholders' meetings. See "Shareholder Proposals and Nominations for the Next Annual Meeting" on page 40 for further information. During fiscal year 2024, the Nominating and Corporate Governance Committee held three meetings.
Genco's ESG Committee, whose members consisted of Karin Y. Orsel (Chair), Kathleen C. Haines , Basil G. Mavroleon , and Arthur L. Regan until July 1, 2024 and, effective July 1, 2024 , Karin Y. Orsel (Chair), Paramita Das , and Arthur L. Regan , leads Board oversight activities regarding ESG and reports to the Board. In that role, the ESG Committee reviews our ESG strategy and assesses our performance, including with respect to such matters as environmental initiatives and sustainability; human capital management and health, safety and security; and corporate responsibility. In addition, the ESG Committee assesses whether relevant ESG matters should be reviewed or considered by other Board committees or the full Board. During fiscal year 2024, Genco's ESG Committee held two meetings. For details of our ESG initiatives, please see "Environmental and Other Regulations" in our Annual Report on Form 10-K filed with the SEC on February 21, 2025 , and our website at www.gencoshipping.com for a copy of our current Sustainability Report.
Executive Sessions
Under the Corporate Governance Guidelines that Genco adopted to assure free and open discussion and communication among the non-management directors, the non-management directors will seek to meet at least annually and may meet as the non-management directors deem appropriate. In addition, if there are any non-management directors who are not independent directors, the independent directors shall meet in executive session at least once each year. The presiding director at any executive session with the non-management or independent directors will be the Chairman if the Chairman is present and is a non-management or independent director (as applicable) and will otherwise be selected by a majority of the non-management or independent directors (as applicable) present at the meeting. All of Genco's directors other than Mr. Wobensmith are currently non-management directors, and one executive session of independent directors was held in fiscal year 2024.
Board Leadership Structure
As noted above, Genco's Board is currently comprised of a majority of independent directors. Genco recognizes that different Board leadership structures may be appropriate for Genco during different periods of
9
time and under different circumstances. Genco believes that its current Board leadership structure is suitable for Genco because it allows Genco to consider a broad range of opinions in the course of its Board deliberations, including those with knowledge of Genco's day-to-day operations and business strategy, as well as those with an experienced independent viewpoint.
Genco's Chairman of the Board is a separate individual from its Chief Executive Officer and contributes to facilitating communication among the directors, organizing the meeting schedules and agendas of the Board, and presiding at Board and shareholder meetings. Genco's Board does not have a policy on whether or not the roles of Chief Executive Officer and Chairman of the Board should be separate and, if they are to be separate, whether the Chairman of the Board should be selected from the non-employee Directors or be an employee. Genco's Board believes that it should have the flexibility to make a determination from time to time in a manner that is in the best interests of Genco and its shareholders at the time of such determination.
Genco's Corporate Governance Guidelines provide the flexibility for Genco's Board to modify or continue Genco's leadership structure in the future, as it deems appropriate.
Risk Oversight
Genco's Board believes that oversight of Genco's risk management efforts is the responsibility of the entire Board. It views risk management as an integral part of Genco's strategic planning process. The subject of risk management is regularly discussed at Board meetings with Genco's Chief Executive Officer and its Chief Financial Officer. Additionally, the charters of certain of the Board's committees assign oversight responsibility for particular areas of risk. For example, Genco's Audit Committee oversees management of risks related to accounting, auditing and financial reporting and maintaining effective internal controls for financial reporting as well as information security. Genco's Nominating and Corporate Governance Committee oversees risk associated with Genco's Corporate Governance Guidelines and Code of Ethics, including compliance with listing standards for independent directors, committee assignments, and conflicts of interest. Genco's Compensation Committee oversees the risk related to Genco's executive compensation plans and arrangements. Genco's ESG Committee oversees risks related to environmental, social, and corporate responsibility matters, including with respect to climate change, human capital management, health and safety, and social and political trends.
10
MANAGEMENT
Information About Our Executive Officers
The following table sets forth certain information with respect to the executive officers of Genco (other than John C. Wobensmith , for whom information is set forth above under the heading "Board of Directors"):
|
|
|
|
|
|
|
|
|
|
Age
|
|
|
Position
|
|
|
|
38
|
|
|
Chief Financial Officer
|
|
|
|
62
|
|
|
Chief Accounting Officer, Treasurer, and Controller
|
|
|
|
38
|
|
|
Chief Commercial Officer
|
|
|
|
|
|
|
|
11
EXECUTIVE COMPENSATION
Compensation Discussion and Analysis
This section describes Genco's compensation program as it relates to its Chief Executive Officer and President, John C. Wobensmith ; its Chief Financial Officer, Peter Allen ; its Chief Accounting Officer, Joseph Adamo ; and its Chief Commercial Officer, Jesper Christensen .
Executive Compensation Practices
Below is a summary of our key executive compensation practices. We believe these practices promote good governance and align the interests of our executive officers with the interests of our shareholders.
|
|
|
|||
|
What We Do
|
|
|||
|
•
|
|
|
Our Compensation Committee, which is comprised solely of independent directors, recommends annual compensation awards for our executive officers to our
|
|
|
|
|
|
||
|
•
|
|
|
The Compensation Committee directly retains an independent compensation consultant,
|
|
|
|
|
|
||
|
•
|
|
|
Our Compensation Committee conducts an annual review of our executive compensation program to confirm it does not create risks that are reasonably likely to have a material adverse effect on the Company.
|
|
|
|
|
|
||
|
•
|
|
|
We make performance-based cash bonus awards under a plan based on achievement of specified performance criteria.
|
|
|
|
|
|
||
|
•
|
|
|
We have historically made equity awards that:
|
|
|
|
|
|
||
|
•
|
|
|
provide for a three-year minimum vesting schedule for named executives, which is up to five years for certain awards granted historically;
|
|
|
|
|
|
||
|
•
|
|
|
do not provide for "single trigger" vesting in the event of a change of control; and
|
|
|
|
|
|
||
|
•
|
|
|
are limited to a total fixed number of shares under our equity plan for which increases are subject to shareholder approval.
|
|
|
|
|
|
||
|
•
|
|
|
We have adopted and maintain stock ownership guidelines for our executive officers and directors.
|
|
|
|
||||
|
What We Do Not Do
|
|
|||
|
•
|
|
|
We do not permit our executive officers to engage in short sales or hedging transactions with regard to compensatory equity awards or to pledge our equity securities as collateral for a loan (with one grandfathered exception).
|
|
|
|
|
|
||
|
•
|
|
|
We do not provide so-called tax "gross-ups" for our executive officers.
|
|
|
|
|
|
||
|
•
|
|
|
We do not provide significant perquisites for our executive officers.
|
|
|
|
|
|
||
|
•
|
|
|
We do not pay dividends on equity awards prior to vesting.
|
|
|
|
|
|
|
|
12
How Compensation is Determined
Role of Compensation Committee.Genco's Compensation Committee oversees Genco's executive compensation program. The Compensation Committee reviews, administers and designs Genco's compensation plans and policies, and recommends such plans and policies to Genco's Board for approval. Genco's Compensation Committee also reviews and approves the corporate goals and objectives relevant to the compensation of Genco's named executives, evaluates corporate performance and the performance of each of Genco's executives, and recommends to Genco's Board the compensation (cash and equity) of Genco's named executives and other key employees.
Each year, Genco's Compensation Committee evaluates each named executive and other key employees to determine if changes in compensation are appropriate. As part of this process, Genco's Compensation Committee reviews summaries that include, as applicable for each individual, salary, bonus, and other cash compensation; severance and change in control benefits; prior grants of equity-based awards; and the value of benefits and perquisites.
Role of Compensation Consultant.Genco's Compensation Committee retained FW Cook, an independent compensation consultant, to assist and advise Genco's Compensation Committee with respect to several aspects of Genco's executive compensation programs and corporate governance. The services that FW Cook was retained for include reviewing and advising Genco on its compensation philosophy, strategy and program; analyzing the appropriateness of a compensation comparator peer group; providing and analyzing competitive market compensation data; analyzing the effectiveness of Genco's compensation programs and making recommendations, as appropriate; providing advice and counsel on best practices in compensation and corporate governance, keeping Genco and its Compensation Committee apprised of trends, developments, legislation and regulations affecting executive and director compensation; and conducting a risk assessment of Genco's incentive compensation programs and making recommendations, as appropriate. As required by rules adopted by the SEC under the Dodd-Frank Wall Street Reform And Consumer Protection Act, Genco's Compensation Committee has considered the relevant factors (including those set forth in Rule 10C-1(b)(4)(i) through (vi) under the Exchange Act) and has determined that FW Cook is independent and has no conflicts of interest.
Role of Management.Genco's Compensation Committee consults with Genco's Chief Executive Officer and, as appropriate, its other named executives regarding their views on their compensation and the compensation of those who report to them directly or indirectly. However, Genco's Compensation Committee makes the final recommendation to Genco's Board with respect to each executive's compensation. None of Genco's named executives determines his own compensation.
Competitive Marketplace Assessment.In order to assess the competitiveness of Genco's executive compensation, Genco's Compensation Committee reviews the compensation arrangements of executives at certain other publicly-traded drybulk and other shipping companies as well as other companies that the Compensation Committee believes are representative of the market place in which Genco competes for executive and managerial talent. The compensation comparator group that Genco's Compensation Committee used in its recommendations for 2024 compensation comprised 13 such companies, listed below. The Compensation Committee believes the compensation information from the comparator group can be helpful, but recognizes that benchmarking data is not definitive and is subject to change from one year to the next. The Compensation Committee uses this information as a general frame of reference and does not target Genco's executive compensation to a specific percentile, instead using company and individual performance as the primary drivers of compensation levels.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
The Compensation Committee, assisted by FW Cook, reviews the compensation comparator group periodically. In addition to its review of the comparator group executive compensation data, the Compensation Committee also reviews general industry executive compensation survey data.
Prior Year Say on Pay Results.At the May 23, 2024 shareholders' meeting, the non-binding advisory vote on executive compensation proposal, or the "say on pay" vote, received support from 87.8% of votes cast. The Compensation Committee considered these results and determined that the results of the vote did not call for any significant changes to the executive compensation plans and programs already in place.
Genco's Compensation Philosophy
Genco's executive compensation program is designed to attract, motivate and retain a talented team of executives who will enable Genco to compete successfully with other drybulk shipping companies. Genco seeks to accomplish this goal in a way that aligns Genco's executives' interests with those of its shareholders and encourages and rewards Genco's executives for achievement of Genco's annual and longer-term performance objectives.
Our compensation framework embodies a system of short-term incentive awards under our Annual Incentive Plan and long-term incentive awards under our 2015 Equity Incentive Plan, each of which is determined in accordance with a small group of focused metrics. For short-term incentive compensation for 2024, the metrics we used are free cash flow and achievement of corporate and individual strategic initiatives as determined in the discretion of our Board. For long-term incentive compensation for 2024, the metrics we used were relative total shareholder retucompared to a performance peer group and an internally adjusted retuon invested capital ratio. A portion of the value of our equity awards for 2024 took the form of restricted stock units ("RSUs") with vesting based on the passage of time, and the remaining portion took the form of performance RSUs ("PRSUs"), the vesting of which will depend on the achievement of the specified metrics. Further details of our compensation framework and awards made under it for 2024 are further described below under "Compensation for Genco's Named Executives for 2024" starting on page 16.
Compensation Objectives
Genco's compensation program is rooted in the principles inherent in "pay for performance." In particular, Genco has designed its compensation program to:
•
|
attract, motivate, retain and reward those executives and managers who have the necessary experience and subject-matter expertise to deliver sustained improvements in shareholder value;
|
•
|
compensate each executive and manager competitively based upon the scope and impact of his or her position as it relates to the success of Genco and on the potential of each employee to assume increasing responsibility within Genco; and
|
•
|
align the interests of Genco's executives with those of Genco's shareholders through the use of short-term cash incentives that are paid on the basis of performance achievements in the year preceding payment and the use of equity-based long-term incentive awards that link reward to improvement in equity value over time.
|
Elements of Compensation
The compensation program for the named executives consists of three main elements: base salaries; short-term (annual) incentives payable in cash on the basis of annual achievement under Genco's Annual Incentive Plan; and long-term, equity-based incentives. The named executives are also eligible to participate in Genco's health and other broad-based programs on the same basis as other U.S. employees and are eligible for paid time off and paid holidays.
Fixed Compensation
Base Salary.Base salaries for the named executives are determined based on the breadth, scope and complexity of the functions performed by each named executive; individual performance, skills, and experience; the competitive labor market for the position; and internal equity considerations. Base salaries are reviewed annually, and may be adjusted to reflect meritorious individual performance assessments; promotions or significant changes in the scope and impact of the position; or market adjustments to reflect shifts in the competitive labor market for the position.
14
Variable Incentive Compensation
In support of Genco's commitment to align compensation with demonstrated performance, a significant portion of the compensation paid to its named executives is incentive-based. Genco's incentive compensation program has been designed to recognize scope of responsibilities, reward demonstrated performance and leadership, motivate future performance, align the interests of the executive with Genco's shareholders and retain the executives through the term of the equity awards, which has historically been for three to five years. Under Genco's current compensation framework, variable incentive compensation in the forms of cash and restricted stock units is awarded to Genco's named executives based on performance relative to certain metrics recommended by the Compensation Committee and approved by the Board.
Cash Incentive Awards.For purposes of determining the amounts of cash bonuses payable to our named executive officers and other employees, the Compensation Committee recommended, and the Board approved, the Annual Incentive Plan described below.
Equity Awards.Genco does not have a specific policy governing the timing of equity awards but intends to make equity awards for a given year in the first quarter of the year. Under the current compensation framework, these awards consist of RSUs that generally vest over a period of time and PRSUs that vest based on achievement of certain metrics following completion of a measurement period. Each RSU or PRSU awarded by Genco represents the right to receive one share of the issuer's common stock, or in the sole discretion of our Compensation Committee, the value of a share of common stock on the date that the RSU or PRSU vests. The Compensation Committee considers the size and form of award when making award decisions.
Historically, unless otherwise determined by Genco's Compensation Committee, each RSU or PRSU award entitles the named executive to dividend equivalent rights. As the executives share commensurately with other shareholders in receiving payments in respect of dividends, they likewise share in the recognition of the current income generation and future change in stock price. Recipients of RSUs or PRSUs receive dividend equivalent payments only upon settlement of these awards after they vest, and any dividend equivalent payments that have accrued in respect of forfeited RSUs or PRSUs are likewise forfeited.
Other Elements
Benefits.Genco's named executives are eligible under the same plans as all other U.S. employees for medical, dental, vision, and disability insurance and are eligible for paid time off and paid holidays. Additionally, Genco matches the 401(k) contributions of our named executives and other employees up to the maximum allowed per year, which was $31,050 in 2024 for our named executives. Genco pays premiums on life insurance and long-term disability insurance for Mr. Wobensmith . Genco believes these benefits are reasonable, competitive and consistent with Genco's overall executive compensation program.
Annual Incentive Plan for Cash Bonuses
Genco's Annual Incentive Plan includes weighted performance criteria to calculate cash bonuses that may become payable to Genco's executive officers and other employees. The Annual Incentive Plan is administered by the Company's Compensation Committee and provides for the establishment from time to time of measurable criteria intended to reinforce a pay for performance framework aligning the interests of executive officers and other employees with those of the shareholders. The method for computing any amount of compensation payable under the Annual Incentive Plan may include, without limitation, the designation of one or more threshold, target, or maximum bonus levels, determination of the bonus amount to be paid at each such level, and the weighting of metrics used to determine the total bonus award.
2015 Equity Incentive Plan
Genco's 2015 Equity Incentive Plan provides for equity awards with respect to shares of Genco's common stock in the form of non-qualified stock options, stock appreciation rights, dividend equivalent rights, restricted stock, RSUs, or unrestricted stock. Awards are available to officers, directors, and executive, managerial, administrative and professional employees of and consultants to Genco or any subsidiary or joint venture of Genco. Genco's Compensation Committee administers the 2015 Equity Incentive Plan and recommends discretionary awards under this plan for approval by Genco's Board.
15
Compensation for Genco's Named Executives for 2024
The year 2024 was a successful year for Genco in which we continued to carry out our comprehensive value strategy centered on three key pillars: paying sizeable quarterly cash dividends to shareholders, low financial leverage, and opportunistically growing our asset base. In particular, management's efforts made the following achievements possible:
•
|
Net Income of
|
•
|
Declaration of
|
Key initiatives and undertakings by management supporting our success in 2024 included the following:
•
|
Deleveraging through the voluntary repayment of approximately
|
•
|
Analyzing and recommending an enhancement to the quarterly dividend calculation by excluding the drydocking capex line item, increasing the cash available for distribution to shareholders.
|
•
|
Continuing to execute on our fleet renewal plan by:
|
•
|
Integrating two 2016-built scrubber-fitted Capesize vessels into our fleet following the acquisition of these vessels at the end of 2023, increasing our earnings power.
|
•
|
Completing the acquisition of the Genco Intrepid, a 2016-built 180,000 dwt Capesize vessel.
|
•
|
Completing the divestiture of four older 169,000 dwt Capesize vessels and one 55,000 dwt Supramax vessel, thereby avoiding approximately
|
•
|
Achieving #1 rank in the Webber Research ESG Report out of 64 public shipping companies for the fourth consecutive year.
|
•
|
Continuing benchmark outperformance through our commercial operating platform.
|
•
|
Extensive public engagement through industry conferences, analyst coverage, and other initiatives.
|
The specific compensation decisions made for each of the named executives for 2024 reflect the achievement of financial, operational, technical, and commercial successes. Genco's Compensation Committee reviewed relevant aspects of Genco's 2024 performance and determined that each of its named executives provided leadership and managerial expertise that enabled Genco to navigate the normally challenging drybulk shipping industry during a time when the war in Ukraine , the Israel-Hamas war, and attacks on vessels in the Red Sea presented heightened difficulties.
Base Salary
For fiscal year 2024, the annual base salary for our named executives were as follows, which were determined by the Compensation Committee to be competitive, reasonable, and appropriate for their respective roles and performance:
|
|
|
|
|
|
|
2024 Salary
|
Chief Executive Officer and President
|
|
|
|
Chief Financial Officer
|
|
|
|
Chief Accounting Officer
|
|
|
|
Chief Commercial Officer
|
|
|
|
|
|
|
|
16
Short-Term Cash Incentives
Cash bonuses are awarded to executive officers under the Annual Incentive Plan, which includes weighted performance criteria to calculate cash bonuses that may become payable to Genco's executive officers and other employees. The Annual Incentive Plan provides for the establishment of measurable criteria intended to reinforce a pay for performance framework. The following table provides details of the metrics and bonus calculations for our named executives for 2024 under the Annual Incentive Plan:
|
|
|
|
|
|
|
Metric
|
|
|
Weighting
|
|
|
Threshold (25%) /Target (100%) / Stretch (200%)(1)
|
Free Cash Flow (FCF)(2)
|
|
|
60%
|
|
|
|
Strategic Initiatives(3)
|
|
|
40% (20% team objectives and 20% individual objectives)
|
|
|
See discussion below
|
|
|
|
|
|
|
|
(1)
|
Bonuses were calculated on the basis of performance relative to each performance metric and its weighting. For each metric there are threshold, target, and stretch levels. In respect of the threshold level for each metric, subject to application of the Compensation Committee's discretion, no bonus amount is generated for performance below the threshold level; 25% of the target bonus amount is generated for performance at threshold; the target bonus amount is generated for performance at the target level; and the maximum of 200% of the target bonus amount is generated for performance at the stretch level. Actual bonus amounts were calculated by linear interpolation between the threshold and the target and between the target and the maximum.
|
(2)
|
Calculated as EBITDA less drydocking, ballast water treatment system, and energy saving device capital expenditures, less projected debt repayment as of the beginning of the year and interest expense, and adjusted for items such as restricted stock, deferred financing costs, impairments, and gain or loss on sale of vessels.
|
(3)
|
Our Board approved annual quantitative and qualitative strategic initiatives for achievement of team and individual objectives to reflect the Company's goals for that year. The team objectives assessed for 2024 included fleet renewal and growth, capital raises, a comparison of TCE versus the Company's internal benchmark and against its peers, comparison of the Company's cost structure versus the budget set forth at the beginning of the year, and the development of the Company's technical management joint venture and the progression of the commercial team. The individual objectives varied for each named executive based on their respective positions and responsibilities as described below.
|
In 2024, the FCF result was approximately $86 million , representing an achievement of 169%. The Board deemed the performance of each of the named executives listed below to be above target for team and individual objectives at 125% for each. The cash bonuses awarded by the Board on the recommendation of the Compensation Committee to each named executive under the Annual Incentive Plan for 2024 were as follows:
17
Committee took into account Mr. Adamo's performance relative to his individual objectives, which included timely and accurate SEC filings of quarterly reports on Form 10-Q and annual reports on Form 10-K; successful implementation of shipping management software; automation of the accounts payable process; improving efficiency of the current staff; and continuing to build a Company culture of accountability and fairness with high corporate governance and ethical standards. Based on the results for the applicable metrics, the Compensation Committee therefore recommended, and Genco's Board approved, a cash bonus award of $231,000 .
Long-Term Equity Incentive Awards
For 2024, long-term equity incentive awards granted under the Company's 2015 Equity Incentive Plan and consisted of RSUs, which vest based on the passage of time, and PRSUs, which vest based on the achievement of certain performance objectives. Each named executive's target long-term equity incentive award value is set considering individual and Company performance, market data and the Company's compensation philosophy to attract, retain, and incentivize top executive talent. Therefore, target award values vary among the named executives and can vary from year to year. For Mr. Wobensmith , the long-term incentive awards were based on a total value of $1,700,000 , $1,000,000 of which were granted in the form of PRSUs, and $700,000 of which were granted in the form of RSU. As for our other named executives, the long-term awards were based on a total value of $650,000 for Mr. Allen , $250,000 for Mr. Adamo , and $700,000 for Mr. Christensen , 50% which were granted in the form of RSUs and the remaining 50% of which were granted in the form of PRSUs. For each named executive, the number of RSUs and PRSUs were determined by dividing each dollar value by the closing price of our stock on the grant date. The Compensation Committee believes this mix of RSUs and PRSUs provides performance incentives that are aligned with shareholder interests and retention incentives for our named executives.
RSUs
RSUs generally vest in one-third increments on each of the first three anniversaries of February 23, 2024 . For details of other circumstances in which the RSUs may vest, see below under "Potential Payments upon Termination or Change-in-Control."
PRSUs
PRSUs generally vest following the completion of achievement of certain metrics during a three-year measurement period from January 1, 2024 to December 31, 2026 . The following table provides further details of the metrics and calculations for our named executives for PRSUs awarded in 2024:
|
|
|
|
|
|
|
Metric
|
|
|
Weighting
|
|
|
Threshold (25%) /Target (100%) / Stretch (200%)(1)
|
Relative Total Shareholder Return(2)
|
|
|
50%
|
|
|
25th Percentile / 55th Percentile / 85th Percentile
|
|
|
|
50%
|
|
|
3.0% / 6.0-6.5% / 11.0%
|
|
|
|
|
|
|
|
(1)
|
The amount of the PRSU award to be vested is calculated on the basis of performance relative to each performance metric and its weighting. For each metric there are threshold, target, and stretch levels. In respect of the threshold level for each metric, subject to application of the Compensation Committee's discretion, no amount is vested for performance below the threshold level; 25% of the target amount is vested for performance at threshold; the target amount is vested for performance at the target level; and the maximum of 200% of the target amount is vested for performance at the stretch level. Actual amounts vested are calculated by linear interpolation between the threshold and the target and between the target and the maximum.
|
18
(2)
|
For purposes of this metric, share price performance is measured at the end of the performance period using a 20 trading day average plus dividends paid (which assumed to be reinvested) and compared to the 20 day trading average share price at the start of the period. This metric is calculated and ranked across the following performance peer group of global drybulk companies:
|
(3)
|
This metric is calculated as Net Operating Profit After Taxes (NOPAT) divided by the sum of debt and shareholders' equity less cash, with potential adjustments for depreciation based on assumed values for the Company's fleet and extraordinary items in the Compensation Committee's discretion.
|
For details of other circumstances in which the RSUs may vest, see below under "Potential Payments upon Termination or Change-in-Control."
2025 Compensation Decisions
For 2025, base salaries for the named executives were increased for Messrs. Wobensmith, Allen, Adamo, and Christensen (to $725,000 , $380,000 , $315,000 , and $410,000 respectively), in each case retroactive to January 1, 2025 . With regard to cash incentive awards under our Annual Incentive Plan, target amounts of these cash incentive awards have been fixed for 2025 as the following percentages of base salary: for Mr. Wobensmith , 125%; for Messrs. Allen and Christensen, 85%; and for Mr. Adamo , 50%. The 2025 equity awards consisted of RSUs and PRSUs on the same terms as was granted on 2024. Mr. Wobensmith received awards of RSUs in amount determined by dividing $760,000 by our closing stock price on the grant date and PRSUs in an amount determined by dividing $1,140,000 by our closing stock price on the grant date. Messrs. Allen, Adamo, and Christensen received awards of RSUs and PRSUS in an aggregate amount determined by dividing $900,000 , $250,000 , and $900,000 , respectively, by our closing stock price on the grant date, with such awards allocated equally between RSUs and PRSUs.
Severance Benefits
Employment Agreement.Genco entered into an employment agreement with John C. Wobensmith , its Chief Executive Officer and President, on September 21, 2007 , as amended on March 26, 2014 , June 23, 2014 , April 30, 2015 , March 23, 2017 , and August 7, 2019 . Genco entered into this employment agreement with Mr. Wobensmith to retain him, particularly in the event of an actual or rumored change in control. The employment agreement provides for payments upon termination of his employment under certain conditions. The provisions under the employment agreement relating to a change in control serve to align Mr. Wobensmith's interests with those of Genco's shareholders by enabling the executive to consider corporate transactions that are in the best interests of Genco's shareholders and its other constituents without undue conceover whether the transactions may jeopardize his employment. For further details of the employment agreement, including provisions regarding severance, see below under the heading "Potential Payments upon Termination or Change-in-Control- Employment Agreement" on page 25.
Tax and Accounting Implications
Deductibility of Executive Compensation
Section 162(m) of the U.S. Internal Revenue Code of 1986 (the "Code") disallows a federal income tax deduction for certain compensation in excess of $1 million per year paid to each of the Company's chief executive officer, chief financial officer and its three other most highly compensated executive officers other than the chief executive officer and chief financial officer. The Company believes that it qualifies for an exemption from U.S. income tax pursuant to Section 883 of the Code, so that any loss of deduction pursuant to Section 162(m) would not be material. To the extent applicable, the Compensation Committee intends to consider Section 162(m) in the future based on the amount of executive income and other factors.
Accounting for Stock-Based Compensation
Genco follows Accounting Standards Codification Topic 718, Stock Compensation, in accounting for non-vested stock issued under the 2015 Equity Incentive Plan.
Risk Assessment
Genco's Compensation Committee is primarily responsible for overseeing the review and assessment of risks arising from Genco's compensation policies and practices. Genco uses a number of approaches to mitigate excessive risk-taking, including significant weighting towards long-term incentive compensation and assessment
19
of qualitative performance in addition to quantitative metrics. Based on its review of Genco's compensation policies and practices, Genco's Compensation Committee determined that the risks arising from Genco's compensation policies and practices for Genco's employees are not reasonably likely to have a material adverse effect on Genco.
Clawback Policy
On November 7, 2023 , our Board of Directors adopted, based on the recommendation of the Compensation Committee, the Genco Shipping & Trading Limited Policy for the Recovery of Erroneously Awarded Compensation (the "Clawback Policy") in order to comply with Section 10D of the Exchange Act, Rule 10D-1 promulgated under the Exchange Act, and the listing standards of the New York Stock Exchange . The Board has designated the Compensation Committee of the Board as the administrator of the Clawback Policy.
The Policy provides for the mandatory recovery of erroneously awarded incentive-based compensation from current and former executive officers of the Company as defined in Rule 10D-1 in the event that the Company is required to prepare an accounting restatement. The recovery of such compensation applies regardless of whether any such executive officer engaged in misconduct or otherwise caused or contributed to the requirement of an accounting restatement. Under the Clawback Policy, the Company may recoup from such executive officers erroneously awarded incentive-based compensation received within a lookback period of the three completed fiscal years preceding the date on which the Company is required to prepare an accounting restatement.
Equity Award Timing Policies and Practices
We do not grant equity awards in anticipation of the release of material nonpublic information and do not time the release of material nonpublic information based on equity award grant dates or for the purpose of affecting the value of executive compensation. In addition, we do not take material nonpublic information into account when determining the timing and terms of such awards. In 2024, we did not grant new awards of stock options, stock appreciation rights, or similar option-like instruments to our named executives.
20
Compensation Committee Interlocks and Insider Participation
No interlocking relationship exists between any of Genco's executive officers or members of Genco's Board or Compensation Committee and any other company's executive officers, Board of Directors or Compensation Committee.
Compensation Committee Report
The Compensation Committee of Genco's Board has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with management and, based on such review and discussions, Genco's Compensation Committee recommended to Genco's Board that the Compensation Discussion and Analysis be included in this proxy statement.
Submitted by the Compensation Committee of Genco's Board:
The Compensation Committee Report does not constitute soliciting material, and shall not be deemed to be filed or incorporated by reference into any other Company filing under the Securities Act, or the Exchange Act, except to the extent that Genco specifically incorporates the Compensation Committee Report by reference therein.
21
Summary Compensation Table
The following table sets forth in summary form information concerning the compensation paid by us for the years ended December 31, 2024 , December 31, 2023 , and December 31, 2022 , to our named executives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Position
(a)
|
|
|
Year
(b)
|
|
|
Salary
($)
(c)
|
|
|
Stock
Awards
($)(1)
(e)
|
|
|
Option
Awards
($)(2)
(f)
|
|
|
Non-Equity
Incentive Plan
Compensation
($)(3)
(g)
|
|
|
All Other
Compensation
($)
(i)
|
|
|
Total
($)
(j)
|
Chief Executive Officer and President
|
|
|
2024
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
2023
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
||
|
2022
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Chief Financial Officer
|
|
|
2024
|
|
|
|
|
|
$711,992(10)
|
|
|
-
|
|
|
$463,000
|
|
|
|
|
|
|
|
2023
|
|
|
|
|
|
$473,021(11)
|
|
|
-
|
|
|
$308,000
|
|
|
|
|
|
$1,118,433
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Chief Accounting Officer
|
|
|
2024
|
|
|
|
|
|
$273,818(12)
|
|
|
-
|
|
|
$231,000
|
|
|
|
|
|
$840,868
|
|
2023
|
|
|
|
|
|
$271,560(13)
|
|
|
-
|
|
|
$160,000
|
|
|
|
|
|
$766,260
|
||
|
2022
|
|
|
|
|
|
$449,992(14)
|
|
|
-
|
|
|
$176,000
|
|
|
|
|
|
$945,392
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Chief Commercial Officer
|
|
|
2024
|
|
|
|
|
|
$766,764(16)
|
|
|
-
|
|
|
$515,000
|
|
|
|
|
|
|
|
2023
|
|
|
|
|
|
$651,722(15)
|
|
|
-
|
|
|
$366,000
|
|
|
|
|
|
|
(1)
|
The amounts in column (e) reflect the aggregate grant date fair value of restricted stock unit (RSU) awards pursuant to Genco's 2015 Equity Incentive Plan computed in accordance with FASB ASC Topic 718. The actual amount realized by the named executive will likely vary based on a number of factors, including Genco's performance, stock price fluctuations and applicable vesting.
|
(2)
|
The amounts in column (f) reflect the aggregate grant date fair value of option awards pursuant to Genco's 2015 Equity Incentive Plan computed in accordance with FASB ASC Topic 718. The actual amount realized by the named executive will likely vary based on a number of factors, including Genco's performance, stock price fluctuations and applicable vesting.
|
(3)
|
The amounts in column (g) were determined in accordance with Genco's Annual Incentive Plan described below.
|
(4)
|
Represents a grant of 38,525 RSUs having a grant date fair value of
|
(5)
|
Represents a grant of 39,877 RSUs having a grant date fair value of
|
(6)
|
Represents a grant of 71,574 RSUs awarded on
|
(7)
|
Represents
|
(8)
|
Represents
|
(9)
|
Represents
|
(10)
|
Represents a grant of 17,887 RSUs having a grant date fair value of
|
(11)
|
Represents a grant of 9,969 RSUs having a grant date fair value of
|
(12)
|
Represents a grant of 6,879 RSUs having a grant date fair value of
|
(13)
|
Represents a grant of 7,669 RSUs having a grant date fair value of
|
(14)
|
Represents a grant of 7,668 RSUs awarded on
|
(15)
|
Represents a grant of 19,263 RSUs having a grant date fair value of
|
(16)
|
Represents a grant of 18,405 RSUs having a grant date fair value of
|
22
The following table reflects awards under Genco's Annual Incentive Plan and 2015 Equity Incentive Plan during the year ended December 31, 2024 :
|
||||||||||||||||||||||||||||||
Grants of Plan-Based Awards
|
||||||||||||||||||||||||||||||
(a)
|
|
|
Grant Date
(b)
|
|
|
Estimated future payouts under
non-equity incentive plan awards
|
|
|
Estimated future payouts under
equity incentive plan awards
|
|
|
All Other
Stock Awards:
Number of
Shares of
Stock
(i)
|
|
|
Grant Date Fair
Value of Stock
Awards
($)(l)(4)
|
|||||||||||||||
|
Threshold
($)(c)(1)
|
|
|
Target
($)(d)(1)
|
|
|
Maximum
($)(e)(1)
|
|
|
Threshold
(#)(f)(2)
|
|
|
Target
(#)(g)(2)
|
|
|
Maximum
(#)(h)(2)
|
|
|||||||||||||
|
|
|
|
|
|
218,750
|
|
|
|
|
|
|
|
|
13,759
|
|
|
55,036
|
|
|
110,072
|
|
|
38,525(3)
|
|
|
|
|||
|
|
|
|
|
|
76,500
|
|
|
|
|
|
$612,000
|
|
|
4,472
|
|
|
17,887
|
|
|
35,774
|
|
|
17,887(3)
|
|
|
$711,992
|
|||
|
|
|
|
|
|
38,125
|
|
|
|
|
|
$305,000
|
|
|
1,720
|
|
|
6,879
|
|
|
13,758
|
|
|
6,879(3)
|
|
|
$273,818
|
|||
|
|
|
|
|
|
85,000
|
|
|
|
|
|
$680,000
|
|
|
4,816
|
|
|
19,263
|
|
|
38,526
|
|
|
19,263(3)
|
|
|
$766,764
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents awards for cash bonuses under our Annual Incentive Plan for the year ended
|
(2)
|
Represents PRSUs awarded for the year ended
|
(3)
|
Represents RSUs awarded for the year ended
|
(4)
|
The grant date fair value for RSUs and the PRSUs contingent on ROIC is estimated in accordance with ASC 718 based on the closing price of the Company's common stock on the date of grant. The grant date fair value for the PRSUs contingent on TSR is estimated in accordance with ASC 718 using a
|
The Company used its historical stock prices and those in the peer group as the basis for its volatility assumptions. The risk-free interest rates were based on U.S. Treasury rates in effect as of the grant date. The expected term was based on the time remaining in the performance period as of the grant date. For further information on the valuation of these awards, see note 17 to our audited financial statements for the year ended December 31, 2024 included in our Annual Report on Form 10-K filed with the SEC on February 21, 2025 .
The following table provides information on awards under Genco's 2015 Equity Incentive Plan outstanding as of December 31, 2024 :
|
||||||||||||||||||
Outstanding Equity Awards at Fiscal Year End
|
||||||||||||||||||
|
|
Option or Warrant Awards
|
|
|
Stock Awards
|
|||||||||||||
(a)
|
|
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
(b)
|
|
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
(c)
|
|
|
Option
Exercise
Price
($)
(e)
|
|
|
Option
Expiration
Date
(f)
|
|
|
Number of Units
that Have Not
Vested
(#)(i)
|
|
|
Market or Payout
Value of Units
That Have not
Vested
($)(j)(1)
|
|
|
|
69,284(2)
|
|
|
-
|
|
|
$9.91
|
|
|
|
|
|
55,036(5)
|
|
|
$853,609
|
|
168,539(3)
|
|
|
-
|
|
|
$7.06
|
|
|
|
|
|
38,525(6)
|
|
|
$597,523
|
||
|
16,691(4)
|
|
|
-
|
|
|
|
|
|
|
|
|
39,877(7)
|
|
|
$636,437
|
||
|
|
|
|
|
|
|
|
|
26,585(8)
|
|
|
$424,297
|
||||||
|
|
|
|
|
|
|
|
|
90,032(9)
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
40,898(10)
|
|
|
$785,241
|
||||||
Total
|
|
|
254,514
|
|
|
-
|
|
|
|
|
|
|
290,593
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
2,178(2)
|
|
|
-
|
|
|
$9.91
|
|
|
|
|
|
17,887(5)
|
|
|
$277,428
|
|
|
|
|
|
|
|
|
|
17,887(6)
|
|
|
$277,428
|
||||||
|
|
|
|
|
|
|
|
|
13,886(7)
|
|
|
$221,033
|
||||||
|
|
|
|
|
|
|
|
|
9,258(8)
|
|
|
$147,365
|
||||||
|
|
|
|
|
|
|
|
|
20,579(9)
|
|
|
$338,730
|
||||||
|
|
|
|
|
|
|
|
|
2,982(10)
|
|
|
$57,254
|
||||||
Total
|
|
|
2,178
|
|
|
-
|
|
|
|
|
|
|
82,479
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23
|
||||||||||||||||||
Outstanding Equity Awards at Fiscal Year End
|
||||||||||||||||||
|
|
Option or Warrant Awards
|
|
|
Stock Awards
|
|||||||||||||
(a)
|
|
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
(b)
|
|
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
(c)
|
|
|
Option
Exercise
Price
($)
(e)
|
|
|
Option
Expiration
Date
(f)
|
|
|
Number of Units
that Have Not
Vested
(#)(i)
|
|
|
Market or Payout
Value of Units
That Have not
Vested
($)(j)(1)
|
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
6,879(5)
|
|
|
$106,693
|
|
|
|
|
|
|
|
|
|
6,879(6)
|
|
|
$106,693
|
||||||
|
|
|
|
|
|
|
|
|
7,669(7)
|
|
|
$122,397
|
||||||
|
|
|
|
|
|
|
|
|
5,113(8)
|
|
|
$81,603
|
||||||
|
|
|
|
|
|
|
|
|
12,862(9)
|
|
|
$211,708
|
||||||
|
|
|
|
|
|
|
|
|
2,556(10)
|
|
|
$49,076
|
||||||
Total
|
|
|
-
|
|
|
-
|
|
|
|
|
|
|
41,958
|
|
|
$678,170
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
13,472(2)
|
|
|
-
|
|
|
|
|
|
|
|
|
19,263(5)
|
|
|
$298,769
|
|
32,771(3)
|
|
|
-
|
|
|
|
|
|
|
|
|
19,263(6)
|
|
|
$298,769
|
||
|
|
|
|
|
|
|
|
|
18,405(7)
|
|
|
$293,744
|
||||||
|
|
|
|
|
|
|
|
|
12,270(8)
|
|
|
$195,829
|
||||||
|
|
|
|
|
|
|
|
|
38,586(9)
|
|
|
$635,126
|
||||||
|
|
|
|
|
|
|
|
|
18,405(10)
|
|
|
$353,376
|
||||||
Total
|
|
|
46,243
|
|
|
-
|
|
|
|
|
|
|
126,192
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The value of the unvested stock awards equals the number of unvested shares or RSUs multiplied by
|
(2)
|
Represents awards of options exercisable for shares of Genco's common stock pursuant to Genco's 2015 Equity Incentive Plan made on
|
(3)
|
Represents awards of options exercisable for shares of Genco's common stock pursuant to Genco's 2015 Equity Incentive Plan made on
|
(4)
|
Represents awards of options exercisable for shares of Genco's common stock pursuant to Genco's 2015 Equity Incentive Plan made on
|
(5)
|
Represents awards of PRSUs pursuant to Genco's 2015 Equity Incentive Plan granted on
|
(6)
|
Represents awards of RSUs pursuant to Genco's 2015 Equity Incentive Plan granted on
|
(7)
|
Represents awards of PRSUs pursuant to Genco's 2015 Equity Incentive Plan granted on
|
(8)
|
Represents the unvested portions of awards of RSUs pursuant to Genco's 2015 Equity Incentive Plan granted on
|
(9)
|
Represents the unvested portions of awards of RSUs pursuant to Genco's 2015 Equity Incentive Plan granted on
|
24
(10)
|
Represents the unvested portions of awards of RSUs pursuant to Genco's 2015 Equity Incentive Plan granted on
|
The following table provides information regarding options exercised and stock awards that vested during the year ended December 31, 2024 , all of which stock awards were RSUs:
|
||||||||||||
Option Exercises and Stock Vested
|
||||||||||||
(a)
|
|
|
Option Awards
|
|
|
Stock awards
|
||||||
|
Number of
Shares
Acquired on
Exercise
(#) (b)
|
|
|
Value Realized
on Exercise
($)(1) (c)
|
|
|
Number of
Shares Acquired
on Vesting
(#) (d)
|
|
|
Value Realized on
Vesting
($)(2)(e)
|
||
|
|
|
-
|
|
|
-
|
|
|
71,320
|
|
|
|
|
|
|
-
|
|
|
-
|
|
|
14,660
|
|
|
$316,714
|
|
|
|
3,413
|
|
|
|
|
|
12,216
|
|
|
$262,122
|
|
|
|
-
|
|
|
-
|
|
|
25,841
|
|
|
$563,763
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The aggregate value realized upon the exercise of an option award represents the difference between the aggregate closing market price of the shares of our common stock on the NYSE on the date of exercise and the aggregate exercise price of the exercised option award. In each case, the value realized is before payment of applicable taxes and brokerage commissions, if any.
|
(2)
|
The value of the unvested stock awards that vested during the year ended
|
Potential Payments upon Termination or Change-in-Control
Employment Agreement
Genco entered into an employment agreement on September 21, 2007 with John C. Wobensmith , Genco's Chief Executive Officer and President, with an initial two-year term and an automatic renewal for additional one year terms, unless either party terminates his employment agreement on at least 90 days' notice. Mr. Wobensmith's salary under his employment agreement may be increased but not decreased and was set at $650,000 per annum under the March 23, 2017 amendment. His employment agreement also provides for discretionary bonuses as determined by Genco's Compensation Committee in its sole discretion; such bonuses are now governed by the Annual Incentive Plan, as discussed above. Mr. Wobensmith will also be eligible to receive restricted stock and other equity grants from time to time pursuant to Genco's 2015 Equity Incentive Plan or any successor employee stock incentive, warrant or option plan. Genco pays for life insurance and long-term disability insurance for Mr. Wobensmith pursuant to his employment agreement at a cost of no more than $20,000 per annum.
Under his employment agreement, Mr. Wobensmith has agreed to protect Genco's confidential information for three years after termination, and not to solicit Genco's employees for other employment for two years after termination. He has also agreed not to engage in certain defined competitive activities described in his employment agreement for two years after the termination of his employment with Genco. Certain provisions regarding competitive activities will only apply for six months following a change of control or in the event of termination of Mr. Wobensmith by Genco without cause or by Mr. Wobensmith for good reason. For purposes of his employment agreement, change of control is defined generally as the acquisition of beneficial ownership of more than 50% of the aggregate voting power of Genco by any person or group; the sale of all or substantially all of Genco's assets within a 12-month period; any merger or similar transaction in which holders of Genco's voting stock immediately prior to such transaction do not hold at least 50% of the voting stock of the surviving entity; the acquisition of beneficial ownership of more than 40% of the aggregate voting power of Genco by any person or group that is required to file a Schedule 13D; or replacement of a majority of the Board is a 12-month period without endorsement by a majority of the pre-replacement Board.
If Mr. Wobensmith is terminated without cause or resigns for good reason, Genco will pay him a pro rata bonus for the year of termination equal to the amount by which his average short-term annual cash bonus over
25
the three prior years exceeds the value of his cash bonus for the year of termination (prorated for length of employment in the year of termination), plus a lump sum equal to double the average of his prior three years' annual incentive awards, plus double his annualized base salary, and provide medical, dental, long-term disability, and life insurance benefit plan coverage for him and his eligible dependents for a period of two years. Genco's nonrenewal of Mr. Wobensmith's employment agreement by giving at least 90 days' notice prior to the end of the then current term is treated as a termination without cause. If a termination without cause or resignation for good reason occurs within two years after a change in control, (i) the amounts that are doubled above become tripled, (ii) the coverage period of two years becomes three years, and (iii) the average of his prior three years' annual incentive awards will instead be the average of his annual incentive awards for the three years immediately preceding the change in control. Mr. Wobensmith's annual incentive award for a given year is his cash bonus earned for that year. Additionally, if a change in control occurs within nine months after termination of Mr. Wobensmith's employment for good reason or other than for cause, death, or disability, the total severance compensation and benefits he will be entitled to receive will be the same as provided in the event of such a termination within two years after a change in control.
In the event of termination of Mr. Wobensmith's employment due to his death or disability, Genco will pay him, or his estate, a pro rata bonus for the year of termination as described above and one year's salary and, in the case of disability, to provide medical, dental, long-term disability, and life insurance benefit plan coverage for him and his eligible dependents for a period of one year.
The table below sets forth the payments and other benefits that would be provided to Mr. Wobensmith upon termination of his employment by Genco without cause or by him for good reason under the following sets of circumstances as described more fully above: change of control, no change of control, and death or disability. In each set of circumstances, Genco has assumed a termination as of the end of the day on December 31, 2024 for purposes of the calculations for the table below:
|
|
|
|
|
|
|
|||
|
|
Termination by Executive for Good
Reason or
by Company without Cause
|
|
|
Death or Disability
|
||||
|
|
Change of Control
|
|
|
No Change of
Control
|
|
|||
Cash Severance Payment
|
|
|
|
|
|
|
|
|
|
Estimated Present Value of Continued Benefits Following Termination(1)
|
|
|
$251,580
|
|
|
$149,540
|
|
|
$76,776
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Accelerated Vesting of Equity Awards
RSUs. Under the terms of Mr. Wobensmith's RSU grant agreements with unvested RSUs remaining, the RSUs vest in full six months after the occurrence of a change of control (as defined under the 2015 Equity Incentive Plan), subject to the individual's continued employment on such date, unless the RSU award is not assumed, continued or substituted for by the acquirer, in which case the RSUs will vest in full immediately upon a change in control. In addition, if Mr. Wobensmith's service is terminated by Genco without cause (as defined in the 2015 Equity Incentive Plan) or he terminates his service for good reason (as defined in his employment agreement, then his RSU grants made in 2024 or later vest in full, and the next yearly tranche of his prior RSU awards vest, subject to vesting in full if termination occurs when Genco is party to a definitive agreement that
26
will result in a change of control or if termination occurs within 12 months after a combination in which either (a) Genco issues more than thirty-five percent (35%) of its outstanding voting stock if it is the survivor or (b) Genco shareholders would collectively own less than sixty-five (65%) of the outstanding voting stock of the combined company if Genco is not the survivor. Also, if Mr. Wobensmith's individual's service is terminated by Genco by reason of his death or disability (as defined in the RSU grant agreement), the RSUs become vested as to a pro rata percentage of the RSUs, calculated monthly, that would otherwise become vested at the next vesting date. For purposes of the RSUs, "service" means a continuous time period during which the individual is at least one of the following: an employee or a director of, or a consultant to, Genco.
Under the terms of the RSU grant agreements of Messrs. Allen, Adamo and Christensen with unvested RSUs remaining, the RSUs vest in full if the individual's service is terminated by Genco without cause within twelve months after the occurrence of a change of control, unless the RSU award is not assumed, continued or substituted for by the acquirer, in which case the RSUs will vest in full immediately upon a change in control. In addition, if the executive's service is terminated by Genco without cause (as defined in the 2015 Equity Incentive Plan), then his RSU grants made in 2024 or later vest in full, and the next yearly tranche of his prior RSU awards vest, subject to vesting in full if termination occurs when Genco is party to a definitive agreement that will result in a change of control or if termination occurs within 12 months after a combination in which either (a) Genco issues more than thirty-five percent (35%) of its outstanding voting stock if it is the survivor or (b) Genco shareholders would collectively own less than sixty-five (65%) of the outstanding voting stock of the combined company if Genco is not the survivor. Also, if the executive's service is terminated by Genco by reason of his death or disability, the RSUs become vested as to a pro rata percentage of the RSUs, calculated monthly, that would otherwise become exercisable at the next vesting date.
PRSUs. Under the terms of Mr. Wobensmith's PRSU grant agreements, the PRSUs vest in full at target six months after the occurrence of a change of control (as defined under the 2015 Equity Incentive Plan), subject to his continued employment on such date, unless the PRSU award is not assumed, continued or substituted for by the acquirer, in which case the PRSUs will vest in full immediately upon a change in control. In addition, if Mr. Wobensmith's service is terminated by reason of his death or disability (as defined in the PRSU grant agreement) or, under his PRSU agreement entered into in 2023, his service is terminated by Genco without cause (as defined in the 2015 Equity Incentive Plan) or he terminates his service for good reason (as defined in his Employment Agreement), the PRSUs become vested as to a pro rata percentage of the PRSUs, calculated monthly, based on the length of performance period served and performance vest and settle based on actual performance at the conclusion of the performance period, subject to vesting in full if termination occurs when Genco is party to a definitive agreement that will result in a change of control or if termination occurs within 12 months after a combination in which either (a) Genco issues more than thirty-five percent (35%) of its outstanding voting stock if it is the survivor or (b) Genco shareholders would collectively own less than sixty-five (65%) of the outstanding voting stock of the combined company if Genco is not the survivor. Under his PRSU agreements entered into after 2023, if Mr. Wobensmith's service is terminated by Genco without cause or he terminates his service for good reason, the PRSUs vest in full at target. For purposes of the PRSUs, "service" means a continuous time period during which the individual is at least one of the following: an employee or a director of, or a consultant to, Genco.
Under the terms of the PRSU grant agreements of Messrs. Allen, Adamo and Christensen, the PRSUs vest in full at target if the individual's service is terminated by Genco without cause within twelve months after the occurrence of a change of control, unless the PRSU award is not assumed, continued or substituted for by the acquirer, in which case the PRSUs will vest in full at target immediately upon a change in control. In addition, if the executive's service is terminated by reason of his death or disability (as defined in the PRSU grant agreement) or, under his PRSU agreement entered into in 2023, by Genco without cause (as defined in the 2015 Equity Incentive Plan), the PRSUs become vested as to a pro rata percentage of the PRSUs, calculated monthly, based on the length of performance period served and performance vest and settle based on actual performance at the conclusion of the performance period. Under the PRSU agreements entered into after 2023, if the executive's service is terminated by Genco without cause, the PRSUs vest in full at target.
Options. All unexercised options awarded to Messrs. Wobensmith, Allen, and Christensen are currently vested and exercisable. Genco's current compensation framework does not include options, although Genco may award options in the future.
27
The table below sets forth the vesting of RSUs and PRSUs under the following sets of circumstances: change of control, termination without cause, and death or disability. In each set of circumstances, Genco has assumed a triggering event as of the end of the day on December 31, 2024 and used the closing market price of Genco's common stock on December 31, 2024 of $13.94 per share and the target amount of PRSUs for purposes of the calculations for the table below.
|
|
|
|
|||||||||||||||
|
|
Value of Equity Awards Subject to Accelerated Vesting ($)
|
||||||||||||||||
|
|
|
RSUs
|
|
|
PRSUs
|
||||||||||||
|
|
Change of
Control
|
|
|
Termination
without Cause
|
|
|
Death or
Disability
|
|
|
Change of
Control
|
|
|
Termination
without Cause
|
|
|
Death or
Disability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$706,841
|
|
|
$177,804
|
|
|
|
|
|
$442,916
|
|
|
$378,392
|
|
|
|
|
|
|
$382,095
|
|
|
$256,810
|
|
|
|
|
|
$202,799
|
|
|
$167,164
|
|
|
|
|
|
|
|
|
|
$574,049
|
|
|
|
|
|
$525,092
|
|
|
$439,570
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief Executive Officer Pay Ratio
For 2024, the total compensation of our Chief Executive Officer of $3,966,753 , as presented in the Summary Compensation Table, was approximately 30.87 times the total compensation of the Company's median employee of $128,497 applying a cost of living adjustment or approximately 126.20 times the total compensation of the Company's median employee of $31,433 without a cost of living adjustment, in each case calculated in the same manner as further described below. We have employees in a number of countries around the world, and a significant proportion of them are employed in India by our GS Shipmanagement Pte. Ltd technical management joint venture. The median employee with or without a cost of living adjustment was identified by reviewing the total cash compensation consisting of salary, bonus, and 401(k) match for all employees, excluding the Company's Chief Executive Officer, who were employed by the Company or its consolidated subsidiaries on December 31, 2024 . We believe such use of total cash compensation is a consistently applied compensation measure because we do not widely distribute equity awards to employees. All of employees of the Company and its consolidated subsidiaries were included. Adjustments were made to annualize the compensation of employees who were not employed by us for the entire year. We applied the World Bank Price Level Ratio of PPP Conversion Factor (GDP) to market exchange rate to adjust the employees' base salary and the median employee's total annual compensation to the cost-of-living in the U.S. , where our Chief Executive Officer resides. We then identified a median from this group, who was an employee located in India . We applied this same process without the cost-of-living adjustment as well, which identified an employee located in India . Foreign currencies were converted into U.S. dollars using exchange rates as of December 31, 2024 . The 2024 annual total compensation was calculated for each median employee using the same methodology used for the Company's Chief Executive Officer as presented in the Summary Compensation Table. Given the different methodologies that various public companies use to determine their chief executive officer pay ratios, the chief executive officer pay ratio reported above should not be used as a basis for comparison between companies.
28
Pay Versus Performance
In accordance with SEC rules, we prepared the analysis set forth below of the relationship between the compensation actually paid to our CEO and other named executives and certain financial performance measures over the last five fiscal years.
Pay Versus Performance Disclosure Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
Value of Initial Fixed
Investment Based on:
|
|
|
||||||||||||
Year
|
|
|
Summary
Compen-
sation Table
Total for CEO
($)(1)
|
|
|
Compensation
Actually
Paid to
CEO
($)(2)
|
|
|
Average Summary
Compensation
Table Total
for Non-CEO
NEOs(3)
|
|
|
Average
Compensation Actually Paid to
Non-CEO NEOs
($)(4)
|
|
|
Total
Shareholder
Return
($)
|
|
|
Total
Shareholder
Return
($)(5)
|
|
|
Net
Income
(millions)
($)
|
|
|
Adjusted
EBITDA
(millions)
($)(6)
|
2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$76.5
|
|
|
|
2023
|
|
|
|
|
|
|
|
|
$820,010
|
|
|
$822,207
|
|
|
|
|
|
|
|
|
$(12.4)
|
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
177.34
|
|
|
|
|
|
$159.4
|
|
|
|
2021
|
|
|
|
|
|
|
|
|
$701,533
|
|
|
$927,498
|
|
|
159.18
|
|
|
|
|
|
$182.0
|
|
|
|
2020
|
|
|
|
|
|
|
|
|
$559,558
|
|
|
$485,153
|
|
|
71.77
|
|
|
$81.82
|
|
|
|
|
|
$71.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The dollar amounts reported in this column are the amounts of total compensation reported for
|
(2)
|
The dollar amounts reported in this column represent the amount of "Compensation Actually Paid" to
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to Determine
Compensation Actually Paid for
CEO
|
|
|
2024
|
|
|
2023
|
|
|
2022
|
|
|
2021
|
|
|
2020
|
SCT Total for CEO
|
|
|
$3,966,753
|
|
|
$3,166,744
|
|
|
$4,906,384
|
|
|
|
|
|
|
Deduction for Amounts Reported under the "Stock Awards" Column in the SCT
|
|
|
(1,890,703)
|
|
|
(1,412,044)
|
|
|
(3,149,984)
|
|
|
(600,000)
|
|
|
(600,001)
|
Deduction for Amounts Reported under the "Option Awards" Column in the SCT
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(300,000)
|
|
|
(338,763)
|
Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year End
|
|
|
$1,372,485
|
|
|
1,376,554
|
|
|
2,827,991
|
|
|
1,141,870
|
|
|
828,851
|
Increase/deduction for Change in Fair Value from prior Year End to current Year End of Awards Granted Prior to year that were Outstanding and Unvested as of Year end
|
|
|
(593,272)
|
|
|
277,223
|
|
|
(50,922)
|
|
|
1,537,011
|
|
|
(565,922)
|
Increase/deduction for Change in Fair Value from Prior Year End to Vesting Date of Awards Granted Prior to year that Vested during year
|
|
|
287,510
|
|
|
630,984
|
|
|
727,009
|
|
|
471,054
|
|
|
(178,198)
|
Plus: Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Reflected in Total Compensation
|
|
|
456,796
|
|
|
215,399
|
|
|
384,332
|
|
|
43,862
|
|
|
30,882
|
Compensation Actually Paid to CEO
|
|
|
$3,599,569
|
|
|
$4,254,860
|
|
|
$5,644,810
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
The dollar amounts reported in this column represent the average of the amounts reported for our named executive officers as a group (excluding
|
29
(4)
|
The dollar amounts reported in this column represent the average amount of "compensation actually paid" to the named executive officers as a group (excluding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to Determine
Compensation Actually Paid
for Non-CEO NEOs
|
|
|
2024
|
|
|
2023
|
|
|
2022
|
|
|
2021
|
|
|
2020
|
Average SCT Total for Non-CEO NEOs
|
|
|
|
|
|
$820,010
|
|
|
|
|
|
|
|
|
$559,558
|
Deduction for Amounts Reported under the "Stock Awards" Column in the SCT
|
|
|
(584,191)
|
|
|
(279,261)
|
|
|
(683,327)
|
|
|
(67,778)
|
|
|
(100,835)
|
Deduction for Amounts Reported under the "Option Awards" Column in the SCT
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(33,889)
|
|
|
(56,931)
|
Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year End
|
|
|
427,375
|
|
|
275,884
|
|
|
624,353
|
|
|
128,988
|
|
|
139,294
|
Increase/deduction for Change in Fair Value from prior Year End to current Year End of Awards Granted Prior to year that were Outstanding and Unvested as of Year End
|
|
|
(167,048)
|
|
|
36,187
|
|
|
(13,231)
|
|
|
151,827
|
|
|
(37,247)
|
Increase/deduction for Change in Fair Value from Prior Year-End to Vesting Date of Awards Granted Prior to year that Vested during year
|
|
|
63,390
|
|
|
88,301
|
|
|
67,587
|
|
|
42,198
|
|
|
(23,453)
|
Deduction for Fair Value as of the Prior Fiscal Year End of Equity Awards Granted in Prior Fiscal Years that Failed to Meet Vesting Conditions in the Fiscal Year
|
|
|
-
|
|
|
(151,520)
|
|
|
-
|
|
|
-
|
|
|
-
|
Plus: Value of Dividends or Other Earnings Paid on Equity Awards Not Otherwise Reflected in Total Compensation
|
|
|
131,163
|
|
|
32,607
|
|
|
56,283
|
|
|
4,618
|
|
|
4,768
|
Average Compensation Actually Paid to Non-CEO NEOs
|
|
|
|
|
|
$822,207
|
|
|
|
|
|
|
|
|
$485,153
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5)
|
The peer group used for this purpose from consists of
|
(6)
|
We have determined that Adjusted EBITDA is the financial performance measure that, in our assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used to link compensation actually paid to our named executives, for the most recently completed fiscal year, to company performance. For a reconciliation of Adjusted EBITDA to Net Income, please see Appendix A.
|
Most Important Performance Measures
The following is a list of seven performance measures that, in our assessment, represent the most important performance measures we used to link compensation for our named executives in 2024 to Company performance:
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
|
|
|
TCE vs. Benchmark
|
|
|
Relative TSR%
|
|
|
|
Free Cash Flow
|
|
|
Cost vs. Budget
|
|
|
Strategic Goals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For a further description of these performance measures, please see Appendix A.
30
The following chart provides a graphical representation of the Compensation Actually Paid to our CEO and the Average Compensation Actually Paid to our Non-CEO NEOs versus the five-year cumulative TSR of the Company and our peer group referenced above in note 5:
The following chart provides a graphical representation of the Compensation Actually Paid to our CEO and Average Compensation Actually Paid to our Non-CEO NEOs versus the Company's Net Income and the Company's selected measure, Adjusted EBITDA:
31
Director Compensation
The following table summarizes compensation earned by directors other than Mr. Wobensmith for the year ended December 31, 2024 :
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
Fees Earned
or Paid in
Cash ($)(1)
(b)
|
|
|
Stock
Awards ($)(2)
(c)
|
|
|
Total
($) (h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$69,395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$97,500
|
|
|
|
|
|
|
|
|
|
$87,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amount indicated represents the total fees for service on the Genco Board of Directors or its committees as described below.
|
(2)
|
The amounts in column (c) reflect the aggregate grant date fair value of RSU awards computed in accordance with FASB ASC Topic 718. The actual amount realized by the director will likely vary based on a number of factors, including Genco's performance, stock price fluctuations and applicable vesting. Following a determination that dividend equivalents for such RSUs are factored into the RSUs' grant date fair value computed in accordance with FASB ASC Topic 718, dividend equivalents received by the directors for such RSUs are no longer separately reported.
|
For fiscal year 2024, each director of Genco other than Mr. Dolphin (who is discussed below) received an annual fee of $75,000 , a fee of $20,000 for an Audit Committee Chair assignment, $10,000 for an Audit Committee member assignment, $15,000 for a Chair assignment for the Compensation Committee, the Nominating and Corporate Governance Committee , or the ESG Committee, and $7,500 for a member assignment to the Compensation Committee, the Nominating and Corporate Governance Committee , or the ESG Committee, each of which was prorated for length of service. Mr. Dolphin received quarterly cash fees during 2024 at the rate of $125,000 per annum for his service as Chairman of the Board plus additional fees of $50,000 for additional service provided by him in the 2024 proxy contest.
For fiscal year 2024, on May 23, 2024 , Mr. Dolphin was granted RSUs with respect to 9,242 shares of Genco's common stock, representing a grant having a dollar value of $200,000 based on the closing price at which Genco's stock was quoted on the NYSE on May 23, 2024 , with fractional shares rounded down. On such date, Mses. Haines and Orsel and Messrs. Mavroleon and Regan were each granted RSUs with respect to 5,776 shares of Genco's common stock, representing a grant having a dollar value of $125,000 based on such closing price, with fractional shares rounded down. No shares of the Genco's common stock are currently outstanding in respect of any of the RSUs. Such shares will only be issued in respect of vested RSUs when the director's service with the Company as a director terminates.
Genco reimburses its directors for all reasonable expenses incurred by them in connection with serving on the Board of Directors or its committees.
Anti-Hedging and Anti-Pledging Policy
Our Board of Directors has adopted a policy containing certain prohibitions on the hedging and pledging of our securities by our directors and executive officers. Our directors and executive officers are prohibited from engaging in hedging transactions involving any compensatory equity securities, which are any of the Company's equity securities received as an award or upon the exercise or conversion of any award under any equity compensation plan of the Company. "Hedging" refers to short sales (that is, selling securities that the individual does not own in the expectation the price will decline) and any transactions (including without limitation purchasing prepaid variable forward contracts, equity swaps, collars, and exchange funds) that hedge or offset or are designed to hedge or offset any decrease in the market value of the securities. Our directors and executive officers are also prohibited from pledging any equity securities of the Company as collateral for a loan or other obligation except for any such pledge in existence and disclosed to the Board of Directors of the Company as of March 19, 2021 , but only to the extent of the equity securities actually so pledged as of such date.
32
Stock Ownership Guidelines
Genco encourages stock ownership by its executive officers and its directors in order to align their interests with the long-term interests of its stockholders. In keeping with this, Genco adopted stock ownership guidelines for its executive officers and directors in 2024. Each executive officer is expected to own a number of shares of Genco common stock valued based on the average closing price of a share of the Company's common stock for the previous calendar year equal to four times annual base salary in the case of our Chief Executive Officer, two times annual base salary in the case of other executive officers, and four times annual base cash retainer in the case of directors. Each executive officer and each director has five years to satisfy these guidelines after the date of their adoption or the date of being designated as an executive officer or becoming a director, whichever is later. Company stock holdings that count toward meeting the ownership requirements include (1) shares owned outright or beneficially by the executive officer or director or his or her immediate family members; (2) shares held in trust for the benefit of the executive officer or director or his or her immediate family members; (3) shares of restricted stock that vest with the passage of time, including shares granted but not vested; and (4) shares issuable upon the settlement of restricted stock units that vest with the passage of time. Unexercised stock options (regardless of exercisability) and unvested performance-based restricted stock units do not count toward meeting the ownership guidelines.
Equity Compensation Plan Information
The following table provides information as of December 31, 2024 regarding the 2015 Equity Incentive Plan:
|
|
|
|
|
|
|
|
|
|
Plan category
|
|
|
Number of securities to
be issued upon exercise
of outstanding options,
warrants and rights
(a)
|
|
|
Weighted-average exercise
price of outstanding
options, warrants and
rights
(b)
|
|
|
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
(c)
|
Equity compensation plans approved by security holders
|
|
|
302,945
|
|
|
|
|
|
1,420,933
|
Total
|
|
|
302,945
|
|
|
|
|
|
1,420,933
|
|
|
|
|
|
|
|
|
|
|
33
PROPOSAL NO. 2
ADVISORY VOTE ON EXECUTIVE COMPENSATION
The guiding principles of Genco's compensation policies and decisions include aligning each executive's compensation with Genco's business strategy and the interests of its shareholders and providing incentives needed to attract, motivate and retain key executives who are important to its long-term success. Consistent with this philosophy, a significant portion of the total incentive compensation for each of Genco's executives directly relates to Genco's financial results and to other performance factors that measure its progress against the goals of Genco's strategic and operating plans, as well as performance against Genco's peers. Shareholders should read the Executive Compensation section of this proxy statement, which shows how Genco's compensation design and practices reflect its compensation philosophy. Genco's Compensation Committee and its Board of Directors believe that Genco's compensation design and practices are effective in implementing its guiding principles.
Genco is required to submit a proposal to shareholders for a non-binding advisory vote to approve the compensation of its named executives pursuant to Section 14A of the Exchange Act. This proposal, commonly known as a "say-on-pay" proposal, gives Genco's shareholders the opportunity to express their views on the compensation of its named executives. This vote is not intended to address any specific item of compensation, but rather the overall compensation of Genco's named executives and the principles, policies and practices described in this joint proxy statement/prospectus. Accordingly, the following resolution is submitted for shareholder vote at the Annual Meeting:
RESOLVED, that the shareholders of Genco Shipping & Trading Limited approve, on an advisory basis, the compensation of its named executives as disclosed in the Proxy Statement for the Genco Annual Meeting, including the Summary Compensation Table set forth in such Proxy Statement and other related tables and disclosures."
As this is an advisory vote, the result will not be binding on Genco, its Board or its Compensation Committee, although the Compensation Committee will consider the outcome of the vote when evaluating Genco's compensation principles, design and practices. Proxies submitted without direction pursuant to this solicitation will be voted "FOR" the approval of the compensation of Genco's named executives, as disclosed in this proxy statement.
THE GENCO BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE "FOR" THE APPROVAL OF THE NON-BINDING RESOLUTION ON EXECUTIVE COMPENSATION (ITEM 2 ON THE ENCLOSED PROXY CARD).
34
PROPOSAL NO. 3
RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS
Our Audit Committee has selected the firm of Deloitte & Touche LLP as Genco's independent auditors to audit the financial statements of Genco for the fiscal year ending December 31, 2025 and recommends that shareholders vote for ratification of this appointment. Representatives of Deloitte & Touche LLP are expected to be present at the Annual Meeting, will have the opportunity to make a statement if they desire to do so and are expected to be available to respond to appropriate questions. The affirmative vote of the holders of a majority of the shares present in person or represented by proxy and voting at the Annual Meeting will be required to ratify the selection of Deloitte & Touche LLP .
The appointment of our independent auditor is not required by law, regulation or Genco's governing documents to be submitted for ratification by our shareholders. However, our Audit Committee is submitting its selection of Deloitte & Touche LLP as the Company's independent auditor for the fiscal year ending December 31, 2025 for ratification by our shareholders as a matter of good corporate practice. If the shareholders fail to ratify the selection, our Audit Committee will reconsider its selection of auditors. Even if the selection is ratified, our Audit Committee in its discretion may direct the appointment of different independent auditors at any time during the year if it determines that such change would be in the best interests of Genco and its shareholders.
Fees to Independent Auditors for Fiscal 2024 and 2023
The following table presents fees for professional services rendered by Deloitte & Touche LLP for the audit of the Company's annual financial statements for fiscal 2024 and fiscal 2023 and fees billed for audit-related services, tax services and all other services rendered by Deloitte & Touche LLP for fiscal 2024 and fiscal 2023.
|
|
|
|
|
|
|
Type of Fees
|
|
|
2024
|
|
|
2023
|
|
|
($ in thousands)
|
|
|
($ in thousands)
|
|
Audit Fees
|
|
|
|
|
|
|
Audit-Related Fees
|
|
|
$0
|
|
|
$0
|
Tax Fees
|
|
|
$51
|
|
|
$49
|
All Other Fees
|
|
|
$0
|
|
|
$0
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In the above table, in accordance with the SEC's definitions and rules, "audit fees" are fees that the Company paid to the auditor for the audit of the Company's annual financial statements included in its Form 10-K and review of financial statements included in its Form 10-Qs and for services that are normally provided by the auditor in connection with statutory and regulatory filings or engagements. "Audit-related fees" are fees for assurance and related services that are reasonably related to the performance of the audit or review of the Company's financial statements and include services associated with primary and secondary offerings of our common stock in the past two fiscal years and other matters related to our periodic public filings; "tax fees" are fees for tax compliance, tax advice and tax planning; and "all other fees" are fees for any services not included in the first three categories.
Pre-Approval Policy for Services Performed by Independent Auditor
The Audit Committee has responsibility for the appointment, compensation and oversight of the work of the independent auditor. As part of this responsibility, the Audit Committee must pre-approve all permissible services to be performed by the independent auditor.
The Audit Committee has adopted an auditor pre-approval policy, which sets forth the procedures and conditions pursuant to which pre-approval may be given for services performed by the independent auditor. Under the policy, the Committee must give prior approval for any amount or type of service within four categories: audit, audit-related, tax services or, to the extent permitted by law, other services that the independent auditor provides. Prior to the annual engagement, the Audit Committee may grant general pre-approval for independent auditor services within these four categories at maximum pre-approved fee levels. During the year, circumstances may arise when it may become necessary to engage the independent auditor for additional services not contemplated in the original pre-approval and, in those instances, such service will require separate
35
pre-approval by the Audit Committee if it is to be provided by the independent auditor. For any pre-approval, the Audit Committee will consider whether such services are consistent with the SEC's rules on auditor independence, whether the auditor is best positioned to provide the most cost effective and efficient service and whether the service might enhance the Company's ability to manage or control risk or improve audit quality. The Audit Committee has delegated to its Chairman authority to approve a request for pre-approval provided that the same is submitted to the Audit Committee for ratification at its next scheduled meeting.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE "FOR" THE RATIFICATION (ITEM 3 OF THE ENCLOSED PROXY CARD) OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS GENCO'S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025 .
36
REPORT OF THE AUDIT COMMITTEE
The role of the Audit Committee is to assist the Board of Directors in its oversight of the quality and integrity of the accounting, auditing and financial reporting practices of Genco and the independence and performance of Genco's auditors. The Board of Directors, in its business judgment, has determined that all members of the Committee are "independent," as provided under the applicable listing standards of the NYSE. The Committee operates pursuant to a Charter. As set forth in the Charter, the Committee's job is one of oversight. Management is responsible for the preparation, presentation and integrity of Genco's financial statements. Management is also responsible for maintaining appropriate accounting and financial reporting principles and practices and internal controls and procedures designed to assure compliance with accounting standards and applicable laws and regulations. The independent auditors are responsible for auditing the annual financial statements, expressing an opinion based on their audit as to the statements' conformity with generally accepted accounting principles, monitoring the effectiveness of Genco's internal controls, reviewing the its quarterly financial statements prior to the filing of each quarterly report on Form 10-Q and discussing with the Committee any issues they believe should be raised with the Committee.
The Committee met with Genco's independent auditors to review and discuss the overall scope and plans for the audit of Genco's consolidated financial statements for the year ended December 31, 2024 . The Committee has considered and discussed with management and the independent auditors (both alone and with management present) the audited financial statements and the overall quality of Genco's financial reporting. Management represented to the Committee that Genco's financial statements were prepared in accordance with generally accepted accounting principles, and the Committee reviewed and discussed the financial statements with management.
The Committee has also discussed with the independent auditors the matters required to be discussed by Statement on Auditing Standards No. 61, Communication with Audit Committees, as currently in effect. Finally, the Committee has received written disclosures and the letter from the independent auditors required by the Public Company Accounting Oversight Board (United States ) Ethics and Independence Rule 3526, Communications with Audit Committees Concerning Independence, as currently in effect. The Committee has discussed with the auditors the auditors' independence.
The members of the Audit Committee are not professionally engaged in the practice of auditing or accounting and are not experts in the field of auditing or accounting, including in respect of auditor independence. Members of the Committee rely, without independent verification, on the information provided to them and on the representations made by management and the independent auditors. Accordingly, the Audit Committee's activities do not provide an independent basis to determine that management has maintained appropriate internal control and procedures designed to assure compliance with accounting standards and applicable laws and regulations. Furthermore, the Audit Committee's considerations and discussions referred to above do not assure that the audit of Genco's financial statements has been carried out in accordance with generally accepted auditing standards, that the financial statements are presented in accordance with generally accepted accounting principles or that Genco's auditors are in fact "independent."
Based upon the Committee's receipt and review of the various materials and assurances described above and its discussions with management and independent auditors, and subject to the limitations on the role and responsibilities of the Committee referred to above and in the Charter, the Committee recommended to the Board that the audited financial statements be included in Genco's Annual Report on Form 10-K for the year ended December 31, 2024 , filed with the Securities and Exchange Commission on February 21, 2025 .
Submitted by the Audit Committee of the Board of Directors:
The Report of the Audit Committee does not constitute soliciting material, and shall not be deemed to be filed or incorporated by reference into any other Genco filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that Genco specifically incorporates the Report of the Audit Committee by reference therein.
37
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information regarding the beneficial ownership of Genco's voting common stock as of March 28, 2025 of:
•
|
each person, group or entity known to Genco to beneficially own more than 5% of Genco's stock;
|
•
|
each of Genco's directors and nominees for director;
|
•
|
Genco's Chief Executive Officer and President,
|
•
|
all of Genco's directors and executive officers as a group.
|
As of March 28, 2025 , a total of 42,959,464 shares of common stock were outstanding and entitled to vote at the Special Meeting. Each share of Genco common stock is entitled to one vote on matters on which Genco common shareholders are eligible to vote. The amounts and percentages of Genco common stock beneficially owned are reported on the basis of regulations of the SEC governing the determination of beneficial ownership of securities. Under the rules of the SEC , a person is deemed to be a "beneficial owner" of a security if that person has or shares "voting power," which includes the power to vote or to direct the voting of that security, or "investment power," which includes the power to dispose of or to direct the disposition of that security. A person is also deemed to be a beneficial owner of any securities as to which that person has a right to acquire beneficial ownership presently or within 60 days. Under these rules, more than one person may be deemed a beneficial owner of the same securities, and a person may be deemed to be the beneficial owner of securities as to which that person has no economic interest.
Any information reported below from sources pre-dating the 1-for-10 reverse stock split effected by the Company on July 7, 2016 has been adjusted to reflect such reverse stock split.
Beneficial Ownership of Directors and Executive Officers
Ownership of Common Stock
|
|
|
|
|||
|
|
Shares of Common Stock Beneficially Owned
|
||||
|
|
|
Number
|
|
|
Percentage
|
|
|
|
743,654(2)(7)
|
|
|
1.72%
|
|
|
|
47,429(3)(7)
|
|
|
*
|
|
|
|
26,829(4)(7)
|
|
|
*
|
|
|
|
103,565(5)(7)
|
|
|
*
|
|
|
|
-(6)(7)
|
|
|
-
|
|
|
|
-(7)(8)
|
|
|
-
|
|
|
|
-(7)(9)
|
|
|
-
|
|
|
|
739(7)(10)
|
|
|
*
|
|
|
|
-(7)(11)
|
|
|
-
|
|
|
|
104,414(7)(12)
|
|
|
*
|
|
|
|
4,378,665(13)
|
|
|
10.19%
|
|
|
|
2,714,503(14)
|
|
|
6.32%
|
|
|
|
3,130,326(15)
|
|
|
7.29%
|
All current directors and executive officers as a group (9 persons)
|
|
|
1,026,630
|
|
|
2.37%
|
|
|
|
|
|
|
|
(1)
|
Unless otherwise indicated, the business address of each beneficial owner identified is c/o
|
(2)
|
Includes 168,539 shares of common stock underlying options that were granted on
|
(3)
|
Includes 2,178 shares of common stock underlying options that were granted on
|
38
(4)
|
Does not include 21,992 RSUs and 22,966 PRSUs that generally vest more than 60 days after
|
(5)
|
Includes 13,472 shares of common stock underlying options that were granted on
|
(6)
|
Does not include 127,734 shares of common stock that may be issuable in settlement of vested restricted stock units, including additional restricted stock units granted in lieu of cash dividends, or 9,856 shares of common stock that may be issuable in settlement of restricted stock units granted on
|
(7)
|
Each restricted stock unit represents the right to receive one share of our common stock, or in the sole discretion of our Compensation Committee, the value of a share of common stock on the date that the restricted stock unit vests.
|
(8)
|
Does not include 6,159 shares of common stock that may be issuable in settlement of restricted stock units granted on
|
(9)
|
Does not include 77,264 shares of common stock that may be issuable in settlement of vested restricted stock units, including additional restricted stock units granted in lieu of cash dividends, or 6,159 shares of common stock that may be issuable in settlement of restricted stock units granted on
|
(10)
|
Does not include 104,605 shares of common stock that may be issuable in settlement of vested restricted stock units, including additional restricted stock units granted in lieu of cash dividends, or 6,159 shares of common stock that may be issuable in settlement of restricted stock units granted on
|
(11)
|
Does not include 22,051 shares of common stock that may be issuable in settlement of vested restricted stock units, including additional restricted stock units granted in lieu of cash dividends, or 6,159 shares of common stock that may be issuable in settlement of restricted stock units granted on
|
(12)
|
Does not include 38,717 shares of common stock that may be issuable in settlement of vested restricted stock units, including additional restricted stock units granted in lieu of cash dividends, or 6,159 shares of common stock that may be issuable in settlement of restricted stock units granted on
|
(13)
|
The address of the reporting person is 55 East 52nd Street,
|
(14)
|
The address of the reporting person is
|
(15)
|
The address of the reporting person is
|
39
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Review and Approval of Transactions with Related Persons
In April 2007 , Genco's Board adopted a policy and procedures for review, approval and monitoring of transactions involving Genco and "related persons" (generally, directors and executive officers, director nominees, shareholders owning five percent or greater of any class of Genco's voting securities, immediate family members of the foregoing). The policy covers any related person transaction that meets the minimum threshold for disclosure in the proxy statement under the relevant SEC rules (generally, transactions involving amounts exceeding $120,000 in which a related person has a direct or indirect material interest) and will be applied to any such transactions proposed after its adoption.
Related person transactions must be approved by the Board or by a committee of the Board consisting solely of independent directors, who will approve the transaction only if they determine that it is in the best interests of Genco. In considering the transaction, the Board or committee will consider all relevant factors, including as applicable (i) the related person's interest in the transaction; (ii) the approximate dollar value of the amount involved in the transaction; (iii) the approximate dollar value of the amount of the related person's interest in the transaction without regard to the amount of any profit or loss; (iv) Genco's business rationale for entering into the transaction; (v) the alternatives to entering into a related person transaction; (vi) whether the transaction is on terms no less favorable to Genco than terms that could have been reached with an unrelated third party; (vii) the potential for the transaction to lead to an actual or apparent conflict of interest and any safeguards imposed to prevent such actual or apparent conflicts; (viii) the overall fairness of the transaction to Genco; and (ix) any other information regarding the transaction or the related person in the context of the merger that would be material to investors in light of the circumstances of the particular transaction. If a director is involved in the transaction, he or she will not cast a vote regarding the transaction.
SHAREHOLDER PROPOSALS AND NOMINATIONS FOR THE NEXT ANNUAL MEETING
Shareholder proposals to be included in our proxy statement for an annual meeting must be provided to us on a timely basis and satisfy the other conditions set forth in SEC regulations under Rule 14a-8 regarding the inclusion of shareholder proposals in company-sponsored proxy materials. For a shareholder proposal to be considered for inclusion in our proxy statement for the 2026 Annual Meeting of Shareholders, we must receive the proposal at our offices in New York, New York , addressed to the Secretary, no later than December 11, 2025 . Such proposals must comply with Genco's By-Laws and the requirements of Regulation 14A of the Exchange Act.
For a shareholder nomination of one or more director candidates for election to the Board to be included in our proxy statement for our 2026 Annual Meeting of Shareholders (a "proxy access nomination") and to be properly brought before such meeting, we must receive information and notice of the proxy access nomination in compliance with the requirements set forth in our Amended and Restated By-Laws, addressed to the Corporate Secretary at our principal executive offices no earlier than December 21, 2025 and no later than January 20, 2026 . Stockholders who intend to solicit proxies for nominations of any director candidates for election to our Board other than those nominated by Genco must comply with the additional requirements of Rule 14a-19(b).
A shareholder proposal that is not intended for inclusion in our proxy statement under Rule 14a-8 or a stockholder nomination of a director candidate that is not a proxy access nomination may be brought before the 2026 Annual Meeting of Stockholders so long as we receive information and notice of the proposal or nomination in compliance with the requirements set forth in our Amended and Restated By-Laws, addressed to the Secretary at our offices in New York, New York , no earlier than December 21, 2025 and no later than January 20, 2026 .
Rule 14a-4 of the Exchange Act governs Genco's use of its discretionary proxy voting authority with respect to a shareholder proposal that is not addressed in the proxy statement. With respect to Genco's 2026 Annual Meeting of Shareholders, if Genco is not provided notice of a shareholder proposal on or after December 21, 2025 , but not later than January 20, 2026 , Genco will be allowed to use its discretionary voting authority when the proposal is raised at the meeting, without any discussion of the matter in the proxy statement.
40
ANNUAL REPORT ON FORM 10-K
Genco will provide without charge a copy of its Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 21, 2025 (without the exhibits attached thereto) to any person who was a holder of Genco common stock on the Record Date. Requests for the Annual Report on Form 10-K should be made in writing, should state that the requesting person held Genco common stock on the Record Date and should be submitted to John C. Wobensmith , President and Secretary of Genco, at 299 Park Avenue , 12th Floor, New York, New York 10171.
HOUSEHOLDING
In order to reduce printing and postage costs, in certain circumstances only one annual report, proxy statement, or Notice of Internet Availability of Proxy Materials, as applicable, will be mailed to multiple stockholders sharing an address unless we receive contrary instructions from one or more of the stockholders sharing an address. If your household has received only one annual report, proxy statement, or Notice of Internet Availability of Proxy Materials, as applicable, we will deliver promptly a separate copy of the annual report, proxy statement, or Notice of Internet Availability of Proxy Materials, as applicable, to any stockholder who sends a written request to John C. Wobensmith , President and Secretary of Genco, at 299 Park Avenue , 12th Floor, New York, New York 10171. If your household is receiving multiple copies of our annual reports, proxy statements, or Notices of Internet Availability of Proxy Materials and you wish to request delivery of a single copy, you may send a written request to John C. Wobensmith , President and Secretary of Genco, at 299 Park Avenue , 12th Floor, New York, New York 10171.
CHARITABLE CONTRIBUTIONS
During fiscal years 2022, 2023, and 2024, the Company did not make any contributions, to any charitable organization in which an independent director served as an executive officer, which exceeded the greater of $1 million or 2% of the charitable organization's consolidated gross revenues.
OTHER MATTERS
At the date of this proxy statement, management was not aware that any matters not referred to in this proxy statement would be presented for action at the Annual Meeting. If any other matters should come before the Annual Meeting, the persons named in the accompanying proxy will have discretionary authority to vote all proxies in accordance with their best judgment, unless otherwise restricted by law.
BY ORDER OF THE BOARD OF DIRECTORS
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Chief Executive Officer and President
|
|
|
||
Dated:
|
|
|
|
|
||
|
|
|
|
|
|
|
41
Appendix A
Compensation Metrics
Free Cash Flowis EBITDA less drydocking, ballast water treatment system, and energy saving device capital expenditures, less projected debt repayment as of the beginning of the year and interest expense, and adjusted for items such as restricted stock, deferred financing costs, impairments, and gain or loss on sale of vessels. Extraordinary general and administrative costs may be excluded in the Compensation Committee's discretion. Calculations are based on the Corporation's current fleet size with adjustments to be made based on the actual number of ships owned during the measurement period.
TCE vs. Benchmarkmeasures actual TCE compared to the relevant benchmark (Platts Scrubber and non-Scrubber Fitted Capesize Index for Capesize vessels and the BSI 58 index of the Baltic Dry Index as published by the Baltic Exchange for our minor bulk vessels) net of commissions and adjusted for our fleet composition and vessel characteristics. We define TCE rates as our voyage revenues less voyage expenses, charter-hire expenses and realized gains or losses on fuel hedges, divided by the number of the available days of our owned fleet during the period.
Cost vs Budgetis measured against the budget at the beginning of each year adjusted for the number of owned vessels and timing of drydockings.
Relative TSR%used a peer group consisting of Star Bulk Carriers Corp. , Diana Shipping Inc. , Golden Ocean Group Limited , Safe Bulkers, Inc. , Pacific Basin Shipping Limited , Pangaea Logistics Solutions Ltd. , Belships ASA , Seanergy Maritime Holdings Corp. , and Thorensen Thai Agencies Plc . Eagle Bulk Shipping was removed from this peer group in 2024 as it ceased to be a publicly traded company in April 2024 .
Strategic Goalsare determined in our Board's discretion. See "Compensation for Genco's Named Executives for 2024" starting on page 16 for descriptions of achievements of each of our named executives that are consistent with such goals.
Reconciliation of Adjusted EBITDA to Net Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
2024
|
|
|
2023
|
|
|
2022
|
|
|
2021
|
|
|
2020
|
|||||||
EBITDA Reconciliation ($ in 000s)
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
Net (loss) income attributable to
|
|
|
$76,401
|
|
|
$(12,870)
|
|
|
|
|
|
|
|
|
|
||||
|
|
+
|
|
|
Net interest expense
|
|
|
10,319
|
|
|
6,113
|
|
|
8,052
|
|
|
15,203
|
|
|
21,385
|
|
|
|
+
|
|
|
Depreciation and amortization
|
|
|
68,666
|
|
|
66,465
|
|
|
60,190
|
|
|
56,231
|
|
|
65,168
|
|
|
|
|
|
EBITDA
|
|
|
|
|
|
$59,708
|
|
|
|
|
|
|
|
|
$(139,020)
|
||
|
|
+
|
|
|
Impairment of vessel assets
|
|
|
6,595
|
|
|
41,719
|
|
|
-
|
|
|
-
|
|
|
208,935
|
|
|
|
+
|
|
|
(Gain) loss on sale of vessels
|
|
|
(16,468)
|
|
|
-
|
|
|
-
|
|
|
(4,924)
|
|
|
1,855
|
|
|
|
+
|
|
|
Loss on debt extinguishment
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
4,408
|
|
|
-
|
|
|
|
+
|
|
|
Other operating expense
|
|
|
5,728
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
|
+
|
|
|
Unrealized loss (gain) on fuel hedges
|
|
|
8
|
|
|
96
|
|
|
(4)
|
|
|
(34)
|
|
|
-
|
|
|
|
+
|
|
|
Adjusted EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$71,770
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42
Attachments
Disclaimer
Proxy Statement (Form DEF 14A)
Pritzker's Proposed Budget Will Take Away Health Coverage From Immigrants Without Legal Status
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News